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ABSTRACT 
 
This study aimed the investigation of the pH-induced complexation of silk 
fibroin (SF) and hyaluronic acid (HA), and the potential use of the films casted from the 
aqueous mixtures of the SF-HA complexes in iontophoretic drug delivery applications. 
In the present study, SF-HA complex coacervation was investigated by 
turbidimetric, conductometric, gravimetric and viscosimetric analysis with respect to 
changes in total biopolymer concentration and biopolymer weight ratio. SF-HA 
complexes were formed within the pH-window of 2.5-3.5 regardless of the total 
biopolymer concentration, biopolymer ratio or mixing order.  
SF-HA aqueous complex mixtures, prepared under previously determined 
conditions, were casted and dried under controlled conditions. The resultant insoluble 
and transparent films were subjected to instrumental analysis such as DSC, XRD, FT-
IR, SEM and AFM. Swelling kinetics of the films was studied for pH window of 2.5- 
7.4 and cyclic swelling test was performed to determine the pH-responsiveness of the 
films. It was shown that films swelled more in alkaline conditions and responded to the 
changes in pH of the medium. The permeability of the films were tested with modified-
diffusion-vessels method at pH 2.5 and 7.4 and it was demonstrated that the complex 
films had higher permeability in alkaline condition. Eventually, iontophoretically 
assisted drug permeation and release studies were performed with a custom-made 
diffusion cell under both passive condition and electric field applied in pulsatile fashion. 
In conclusion, SF-HA complex films were found promising for the iontophoretic 
delivery of high molecular weight and charged drugs for a membrane-permeation 
controlled formulation. In this study, timolol maleate (TM) was used as the model drug. 
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ÖZET 
 
Bu çalışmada, ipek fibroin (SF) and hyaluronic asitin (HA) pH’a bağlı olarak 
kompleks oluşturması ve sıvı karışımda oluşan kompleks çözeltilerin dökümü ve uygun 
şartlar altında kurutulması sonucunda elde edilen filmlerin iyontoforetik ilaç salım 
sistemlerinde kullanılma potensiyeli araştırılmıştır.  
SF-HA kompleks koazervasyonu, turbidimetrik, kondaktometrik, gravimetrik ve 
vizkozitemetrik yöntemlerle incelenmiş ve toplam biyopolymer konsantrasyonu ve 
karışımda bulunan biyopolymerlerin ağırlık oranları açısından incelenmiştir. Bu 
analizler sonuncunda, SF-HA kompleks oluşumu, toplam biyopolymer konsantrasyonu, 
polymerin karışım oranı ve karışım sırasından bağımsız olarak pH 2.5-3.5 aralığında 
gerçekleşmiştir. En fazla koazervasyon maksimum turbidite ve minimum vizkozite 
değerlerinde elde edilmiştir. 
Belirlenen şartlar altında hazırlanan kompleks karışımından filmler dökülmüş ve 
kontrollü olarak kurutulmuştur, ve sonuç olarak suda çözünmeyen, şeffaf, ipek filmlere 
göre mekanik olarak daha dayanıklı filmler elde edilmiştir. Elde edilen filmler DSC, 
XRD, FT-IR, SEM ve AFM cihazları aracılığıyla karakterize edilmiştir. Filmlerin şişme 
kinetiği pH 2.5 - 7.4 aralığında çalışılmış ve filmlerin pH duyarlılığını ölçmek için 
siklik şişme testi uygulanmıştır. Kompleks filmlerin alkalin ortamda daha fazla şişme 
gösterdiği ve pH değişimlerine duyarlı olduğu tespit edilmiştir. Buna bağlı olarak da 
farklı pH değerlerinde (2.5 ve 7.4) gerçekleştirilen geçirgenlik deneylerinde alkalin 
ortamda daha fazla ilaç geçirgenliği gösterdiği belirlenmiştir. Son olarak, hem pasif 
durumda hem de kesikli elektrik alan uygulaması altında iyontoforetik ilaç geçirgenliği 
ve ilaç yüklenmiş filmden ilaç salımı özel yapım difüzyon hücresi kullanılarak 
incelenmiştir. SF-HA kompleks filmlerin kontrollü ilaç iletimi için kullanılabileceği 
gösterilmiştir. İlacın kesikli tarzda kontrollü salımı başarılmıştır. Çalışmada model ilaç 
olarak timolol maleate kullanılmıştır.   
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CHAPTER 1 
 
INTRODUCTION 
 
Controlled delivery of drugs to achieve predictable and reproducible drug 
concentration in the blood stream is the aim of the search on the alternative routes for 
drug administration. Production of new peptide-based drugs due to extensive research in 
genetics has accelerated the studies in this area, as these drugs require specific 
conditions for effective delivery regimes. 
Transdermal drug delivery is an alternative route for drug delivery. It offers 
many important advantages over oral drug delivery, e.g., avoids gastrointestinal tract 
and hepatic first pass biotransformation and metabolism, controls absorption rate, 
increases patient compliance, and provides ease of termination if needed. There is a 
number of successful transdermal drug delivery systems commercially available at 
present. However, the need remains to extend their operating parameters so that more 
sustainable and variable delivery regimes can be achieved. Iontophoresis is a process, 
by which the transport of ions into and through the skin is increased by the application 
of an external field. This process has been used to enhance controlled transdermal 
delivery of the drugs which have low permeability through the skin such as hydrophilic, 
very lipophilic, of high molecular weight or charged ones, e.g. peptide-based drugs. 
The heart of the transdermal therapeutic systems is the transdermal patch. 
Transdermal patches are polymeric materials that can be in the form of a membrane 
controlled permeation system including a reservoir or matrix-diffusion controlled 
system in which the drugs were dissolved or evenly distributed. Several synthetic 
natural polymeric systems have been attempted to meet the needs of an effectively 
functioning transdermal patch. Polyelectrolyte membranes comprising natural and/or 
synthetic polymers have been found promising for the iontophoretic transdermal drug 
delivery systems since they have high responsiveness to the environmental changes 
such as to alterations in ionic strength, pH or electric field of the system. 
The phenomena of interpolymer interactions have been the focus of intensive 
fundamental and applied research on polyelectrolyte complexes (PECs). The PECs 
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prepared from natural polymers such as proteins and polysachharides have the 
additional advantage of being non-toxic and bioabsorbable. 
Protein-polyelectrolyte interactions have been concerned widely with 
biotechnological and biomedical applications such as protein purification, enzyme 
immobilization, immunosensing and bioactive sensors. Several globular proteins and 
polyelectrolytes (natural or synthetic) have been matched for various techniques and 
objectives of investigation. Protein-polyelectrolyte interactions often leading to 
coacervation and resulting in biopolymer complexes arises mainly from electrostatic 
interactions. This complexation is dependent on the ionization degree of these 
macromolecules and thus the pH. The aqueous complexation mixtures obtained under 
specific conditions can be processed into several forms such as films, gels, sponges, etc. 
The recent trend is to replace the natural biopolymers used with the new ones to allow 
precise control over resultant material properties along with the opportunity.  
Several researches have been concentrated on the PECs that occur in protein-
polyelectrolyte mixtures. However, silk fibroin and hyaluronic acid complexation has 
not been studied in terms of complex coacervation. Fibroin, a fibrous silk protein, is 
produced by silkworm Bombyx mori, is an excellent film former. This protein has been 
found to be a good starting material for preparation of fibroin-based materials such as 
gel, powder or film, and it has potential uses in contact lenses, artificial corneas, burn 
wound dressings, artificial lungs and drug delivery devices. On the other hand, HA is a 
natural anionic polysaccharide that has been used in the formation of PECs. It is 
considered as an attractive building block for the production of novel biomaterials with 
potential applications in drug delivery and tissue engineering.  
 The specific objectives of this work were to investigate the complex formation 
between SF and HA, to characterize the films produced by this complexation and to 
determine the capability of the complex films, whether they can be utilized in 
iontophoretically assisted transdermal drug delivery systems.  
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CHAPTER 2 
 
REVIEW OF LITERATURE 
 
2.1. Controlled Drug Delivery 
 
The development of newer and more powerful drugs and the need for prolonged 
and better control of drug administration are the leading factors for the search of the 
alternative ways of drug administration. In the light of advancing technologies such as 
genome mapping, there has been a dramatic increase in peptide and protein drugs that 
are mostly injectable. These facts reveal that there is a great commercial potential for 
the controlled delivery systems that uses the alternative routes (Fletcher 1998).  
Studies on drug delivery systems were initiated to achieve the controlled 
delivery of drugs for predictable and reproducible rate of drug input to the blood stream 
to enhance the treatment of the diseases. The initial aim in the field of controlled drug 
delivery has been attaining sustained zero-order release of a therapeutic agent over a 
prolonged period of time (Sershen and West 2002). Zero-order kinetics have been 
attempted by using several techniques including, osmotically driven pumps, matrices 
with controllable swelling, diffusion or erosion rates, non-uniform drug loading profiles, 
and multilayered matrices. 
Recently, the biologically active peptides have been artificially synthesized by 
genetic engineering techniques. These peptides are easily degraded under physiological 
conditions and they may also encounter absorption problems due to their high molecular 
weight. Hence, they cannot be utilized in conventional dosage forms. Moreover, in 
order to maximize efficiency and minimize side effects, the new generation of drug 
delivery systems has been attempted. The challenge appeared to be the controlled 
delivery of a therapeutic molecule, gene or protein in a pulsatile or staggered fashion 
when the drug is required or by targeting the drug to a specific site in addition to 
utilizing the conventional rate-controlling systems. By these means, the recent 
improvements on controlled drug delivery can be examined by a division into two 
classes: temporal control and distribution control (site-specific delivery) as shown in 
Figure 2.1 below (Kumar M. and Kumar N. 2001, Okano and Yoshida 1993).  
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Figure 2.1. Rate control mechanisms in new generation drug delivery systems 
(Source: Okano and Yoshida 1993). 
 
In case of temporal control, the drug release is achieved over an extended period 
or at a specific time during treatment. This can be achieved by constructing a pre-
programmable system that can deliver the agent at a pre-set rate or in pulses of a 
predetermined sequence. Alternatively, a responsive system can be formulated that can 
respond to alterations in the local environment such as pH, electric field, temperature, 
absence or presence of a specific molecule (Kost and Langer 2001). In case of 
traditional administration routes, fluctuations occur in the blood plasma levels. By the 
temporal control, the rate of drug release matches the rate of drug elimination, and 
hence the concentration of drug stays within the therapeutic window (effective drug 
plasma range between the excessive toxic level and subtherapeutic level) during a 
specified interval (Figure 2.2). This avoids waste of drug and toxic effects due to 
overdosing while maximizing the benefits of the drug. 
On the other hand, the distribution control aims the “target release” of the drug 
to the precise site of activity. This improvement is especially beneficial for the cases 
when the traditional routes are not capable of distributing the drug molecules to the site 
action or when the natural distribution caused side effects as the drug molecules 
encounter tissues as in the case of chemotherapy (Kumar M. and Kumar N. 2001). 
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Figure 2.2. Controlled drug delivery versus immediate release 
(Source: Kumar M. and Kumar N. 2001). 
 
2.2. Transdermal Drug Delivery 
 
The improvements in controlled drug delivery regimes provides a competitive 
situation between the administration routes, which can be listed as peroral (osmotic 
minipumps), transdermal (membrane/matrix), oral (targeted formulations), parenteral 
(nanoparticles and nanocapsules), subcutenaous (implants), intracavitary, nasal, buccal, 
etc. (Vasil’ev et al. 2001). Among these controlled drug delivery systems, transdermal 
therapeutic systems has gained considerable success while generating lots of interest 
with the ongoing enhancements on this technique and has found wide applications. 
Transdermal drug delivery systems offer the controlled plasma levels of potent 
drugs with short biological half-lives. These systems allow the administration of drugs 
with narrow therapeutic window. By this parenteral route of administration, the 
potential irritant side effects of the drugs on the gastrointestinal tract can be decreased. 
In addition to this, transdermal administration brings out the bypass of the hepatic first-
pass metabolism, which may result in lost of activity or generation of toxic metabolites. 
By this way, the drug wasted by the metabolism is also avoided, and hence the dose to 
be administered decreases. On the other hand, when compared to other mucosal routes, 
proteolytic activity is relatively low in skin, and this reduces the degradation at the site 
of administration (Banga et al. 1999). This noninvasive technique minimizes trauma, 
risk of infection, damage to the wound. Additionally, the continuous mode of 
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administration increases patient compliance to the therapy and it brings out the ease of 
discontinue the delivery in case of toxic effects. 
The skin, as the largest organ of the human body with a surface area of about     
2 m2, was thought to function just as an impermeable barrier that precludes the entry of 
foreign agents into the body (Stamatialis et al. 2002). By the development of 
transdermal drug administration systems, skin gained another function as a route of 
administration for the topical or continuous systemic delivery of drugs. Transdermal 
administration comprises stage-wise delivery of the drug. The first stage is the delivery 
of the drug molecule from the transdermal device (acting as a reservoir) to the skin 
surface. The second stage is the permeation of the molecule through the skin and the 
final stage includes the distribution of the molecule to the site of action via systemic 
circulation. Thus, permeation rate limiting factor is characterized by the drug 
permeation properties of either the skin or the membrane, or both. Obviously, the 
release of the drug from the device can be controlled more exactly than the permeability 
of drug in the skin. In passive delivery the transport of the molecule across the stratum 
corneum, the outermost layer of the skin, is the rate-limiting step since this layer 
constitutes the most impermeable membrane in humans with its rigidly arranged, 
lipophilic structure. The controlled transdermal delivery systems are designed so that 
the delivery from the device, by the diffusion of the molecule in a polymeric membrane 
of the product, is the rate-limiting step. The main drawback of these systems is seen for 
the drugs that require high blood levels and for the drugs that are charged, of high 
molecular weight, hydrophilic or very lipophilic (Wang et al. 2005).  
Biological factors of transdermal drug delivery, which are generally less easily 
controlled, can be summarized as the intra- and intersubject variability, the regional 
blood flow and the skin pH. This underlines the need of the individual dosage even for 
the same patient for the variable states that determine the sweat counterflow, skin 
temperature, etc (Vasil’ev et al. 2001). Better control of biological variability in 
transdermal drug absorption has been attempted with enhanced systems. Selection of 
external conditions (e.g. ionic strength, pH) and/or drug properties (e.g. charge, 
lipophilicity, molecular weight, etc.) and the enhancements on the characteristic 
properties of the transdermal device can be applied to control the release kinetics of a 
drug from transdermal systems. By such manipulations, controlled drug delivery can be 
promisingly achieved by the transdermal therapeutic systems to obtain presumably 
reproducible drug delivery.  
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2.2.1. Enhancement of Transdermal Permeation 
 
2.2.1.1. General Aspects 
 
The first transdermal drug delivery system (TDDS) was developed for 
scopolamine for motion sickness in 1981 (Panchagnula 1997). Since then many TDDS 
have appeared in market with great success, but the need remains to extend their 
operational parameters to obtain more sustainable and variable delivery regimes. 
Inherent limitations of TDDS stems from the variability of physico-chemical properties 
of the penetrant, low drug levels in plasma and skin irritation caused by some drugs or 
formulations. Passive permeability of drugs across the highly lipophilic stratum 
corneum is especially difficult to compounds which are hydrophilic, very lipophilic, of 
high molecular weight (MW > 400 g/mol) or charged (Wang et al. 2005, Vasil’ev et al. 
2001). Several approaches to overcome these problems and to enhance the transdermal 
drug delivery are summarized in Table 2.1.  
 Approaches to increase the drug permeation across the skin to achieve and 
maintain therapeutic concentration of drug in blood can be expressed as: chemical, 
biological and physical approaches. Chemical enhancers such as sorption promoters or 
biological enhancement studies such as synthesis of bio-convertible pro-drugs have 
been found to increase transdermal drug transport via several mechanisms, including 
increased drug partitioning into the stratum corneum, fluidization of the lipid bilayers, 
and disruption of the intracellular proteins. Even though chemical enhancers have the 
potential to alter the properties of skin, many of them are irritants, and safe and effective 
methods to be used in this field properly are still under development (Sebastiani et al. 
2005). In case of prodrugs, enhancement can be accomplished due to enzymatic activity 
in the epidermis; however, high prodrug concentration in the skin can lead to enzyme 
saturation, which hinders the conversion of the prodrug into an active drug molecule.     
Physical approach mainly includes sonophoresis (phonophoresis), iontophoresis 
and electroporation techniques. Sonophoresis is the application of ultrasound 
(Mitragotri et al. 1995) whereas iontophoresis and electroporation refer to “low-
voltage” and “high voltage” treatments, respectively (Pachagnula 1997). Iontophoresis 
acts primarily on the drug by variable applications while electroporation acts on the 
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lipid bilayer of the skin and creates transient aqueous pathways by short high-voltage 
pulses (Banga et al. 1999).  
 
Table 2.1. Methods to enhance transdermal permeability of macromolecular drugs. 
 
Method Mode of Action 
Chemical enhancers Compromisation of the tightly structured stratum corneum lipid bilayers 
Lipid vesicles Cumulation of drugs in the stratum corneum 
Iontophoresis Low current/voltage electrostatic repulsion, electroosmosis 
Low-frequency ultrasound Local thermal effect, weakened bilayers of the stratum corneum by cavitation 
Electroporation High voltage short term electrical pulses 
(Micro)needles Transient holes in the skin 
Pressurised He-gas Invasive "gene-guns" 
 
There are also several attempts such as creating a synergistic effect on 
transdermal drug delivery by a combined approach. The use of iontophoresis with a 
chemical enhancer is proposed to achieve higher drug penetration, whereas it may also 
reduce the side-effects such as irritation caused by high concentration of enhancers or 
stronger electric forces. Combination of iontophoresis and electroporation is suggested 
for further enhancement of drug transport since it may allow rapid delivery of a bolus 
dose with a precise control of drug delivery modulation and programmability. Synergy 
between low-frequency ultrasound and iontophoresis has been found to increase the 
transdermal drug transport to a greater degree. On the other hand, as reported, the 
combination of microneedles and iontophoresis may offer the possibility of 
macromolecule transdermal delivery with precise electronic control (Wang et al. 2005, 
Pachagnula et al. 2000, Sebastiani et al. 2005). Iontophoresis applications in 
conjunction with ion-exchange materials has also provided promising improvements on 
transdermal drug transport (Jaskari et al. 2000).  
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The novel approaches in transdermal drug delivery are obviously built around 
iontophoresis showing that iontophoresis could be the answer for the effective 
transdermal drug delivery, especially for the novel biotechnologically developed drugs 
such as peptides and proteins that are hydrophillic, charged macromolecules and 
susceptible to proteolysis, chemical change and denaturation (Banga et al. 1999, Tabata 
and Ikada 1998). 
 
2.2.1.2. Iontophoresis 
 
Iontophoresis is a transport phenomenon, and it stems from the movements of 
ions in solution due to an applied electric field across two electrodes. Iontophoretic drug 
delivery implies the use of small amounts of physiologically acceptable electric current 
across a membrane to drive charged molecules into the body. By using an electrode of 
the same polarity as the charge of the drug, the drug is driven into the skin by 
electrostatic repulsion (Stamatialis et al. 2002) as illustrated in Figure 2.3 below. The 
electric field applied results in an electric current, which is transformed into an ionic 
current at the electrode/liquid or electrode/skin interface. This ionic current carries the 
drug ions into the skin while the counter-ions that are more mobile complete the circuit 
(Coston and Li 2001).  
 
 
Figure 2.3. Diagram of iontophoretic technique: as current is applied, drug cations are 
repelled into the skin and absorbed in the systemic circulation 
(Source: Wang et al. 2005). 
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In addition, bulk fluid flow or volume flow occurs in the same direction as the 
flow of counter-ions. This phenomenon, which accompanies the electrostatic repulsion, 
is called electro-osmosis. By the contribution of electroosmosis and increased passive 
permeation (increased permeability of the skin) by the applied potential difference 
across the skin, the transport rate of uncharged and zwitterionic molecules is also 
increased (Sebastiani et al. 2005). 
Numerous attempts have been made to define the rate of iontophoretic flow. The 
rate equation would include flux due to electrochemical potential gradient across the 
skin, change in the skin permeability due to applied electric field and the electro-
osmotic flow. The general rate equation including these flux terms is given as: 
 
convectivepassiveelectricionto JJJJ ++=        (2.1) 
 
 electricJ  is the flux due to electric current application; passiveJ  is the flux due to 
passive delivery through skin and convectiveJ  is the flux due to convective transport due to 
electroosmosis (Singh et al. 1994). 
There are several factors affecting the results of iontophoresis. These include the 
physico-chemical properties of the drug (molecular size, charge, hydrophobicity, 
concentration), drug formulation (type of the system, buffer, pH, viscosity, presence of 
other ions), equipment used (available current range, constant vs. pulsed current, type of 
electrode), biological variations (skin site, regional blood flow, age, sex), skin 
temperature and duration of iontophoresis (WEB_1 2003).  
The skin surface’s isoelectric point (IEP) ranges from 3 to 4, which is about the 
isoelectric point of keratin in the stratum corneum layer. Therefore, for a drug donor 
solution with a pH value higher than the IEP of the skin surface, skin is a negatively 
charged membrane, and hence the electroosmotic flow may enhance the delivery of 
positively charged drug permeation across the skin. In this point of view, the anodic 
delivery is facilitated, whereas the cathodic delivery is retarded by the electroosmotic 
flow, in addition to being a major mode of transport for neutral molecules 
(Panchangnula et al. 2000). However, it was reported that electro-repulsion constitutes 
the dominant mechanism for the transdermal iontophoresis of the ionic smaller solutes, 
whereas electroosmosis becomes more important in the transport of larger ions such as 
proteins as shown by the study of Guy et al. (2000). These findings suggest that the 
charge of the skin rather than the charge of the permeant may be the predominant 
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transport mechanism depending on the physicochemical properties of the drug. This 
dictates that the iontophoretic delivery regimes can be manipulated by changing the pH 
of the formulation (Panchangnula et al. 2000).  
Over the years a wide range of protein and peptides such as tyrotropin-releasing 
hormone (Huang et al. 1996), vasopressin (Banga et al. 1995), calcitonin (Chang et al. 
2003), LHRH (Luteinizing Hormone Releasing Hormone) (Raiman et al. 2004) and 
human parathyroid hormone (Medi et al. 2003). These studies approved that 
iontophoresis not only achieves enhanced transdermal drug transport but the lag time 
required for the delivery is also reduced.  
Consequently, iontophoresis provides a means of local, non-invasive, painless 
drug administration when compared with the traditional administration. Importantly, 
iontophoresis can be used to deliver peptides and protein drugs not suitable for oral 
administration (Green et al. 1992). The technique has been observed to enhance the 
transdermal permeation of varying types of drugs several fold and this shows that 
iontophoresis is promising to make a lasting impact in drug delivery. Most importantly, 
this method also offers the possibility of an individualized dose titration by modulation 
of the current density. The adjustable and pre-programmable drug delivery is the unique 
opportunity of the iontophoresis and parallel developments in the fields of 
bioengineering and microelectronics support the improvements on the iontophoretic 
technique. This is specifically important for some therapies such as Parkinson’s disease 
since an individual dose arrangement is required to obtain an optimum therapy with the 
minimum side effects (Nugroho et al. 2005).  
 
2.2.2. Polymeric Systems in Transdermal Drug Delivery 
 
The earliest drug delivery systems, first introduced in 1970s, were based on 
polymers. Today, polymeric materials still provide the most important material of 
choice for research, primarily because of the ease of processing and control over their 
chemical and physical properties. The polymeric controlled delivery systems are being 
applied for a wide range of drugs in various environments. These systems can be 
formulated as hydrogels, films, membranes, matrices or tablets. Such polymeric systems 
usually contain a base polymer, a plasticizer to provide a suitable degree of flexibility 
and an excipient. The excipients are water-soluble materials that, as they leave the 
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matrix, create channels in the polymeric material and hence facilitate the diffusion of 
the drug. The choice of the prepared polymeric materials suitable for delivery systems 
characterized by several factors as biocompatibility, environmental stability during the 
time of complete drug delivery, appropriate mechanical and thermal properties, 
appreciable swelling characteristics, ease of fabrication and cost (Kumar M. and Kumar 
N. 2001).  
Controlled release of active agents from a polymeric delivery system can be 
tailored by three primary mechanisms: diffusion, degradation and swelling followed by 
diffusion. These mechanisms can stand alone or all may exist in a given release system. 
Polymer structure is the key parameter for the diffusion through polymers, whereas the 
macromolecular structure is effective on diffusion as it influences the rate of 
partitioning into the medium. On macroscopic scale the diffusion can occur through the 
pores in the polymer membrane/matrix, and on molecular level, by passage of the drug 
molecules between polymer chains. In case of transdermal drug delivery, there exists 
additional series of diffusional and active transport steps after the penetration of the 
drug through the skin (Brannon-Peppas 1997).  
In transdermal drug delivery systems, skin is utilized for the delivery of a drug 
via polymeric patches and the drug release from these patches can be controlled by two 
mechanisms: membrane permeation controlled and matrix diffusion controlled systems 
(Jain et al. 2003). Vasil’ev et al. (2001) claimed that these two systems do not differ in 
principal on the drug delivery, both capable of achieving the effective plasma 
concentration for a prolonged period of time.  
Matrix and membrane systems may be developed as various combinations of 
hydrophilic and lipophilic polymers, whether natural or synthetic. 
The membrane system mainly consists of a reservoir where the drug is loaded, a 
membrane that does not contain any drug but serves to control the rate of release of the 
drug from the reservoir. Other components of the system are a drug-impermeable cover 
film (mechanically fastening the whole system and preventing the drug from diffusing 
in undesired directions and from loss on storage) and a pressure sensitive biocompatible 
adhesive for mounting the patch on the skin (Figure 2.4).  
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Figure 2.4. Schematic illustration of a iontophoretic transdermal delivery patch 
composed of a membrane/reservoir system  
(Source: Stamatialis et al. 2002). 
 
In the membrane type systems, reservoir is employed to supply the drugs, 
dissolved or dispersed in liquid phase (solvent) or entrapped in a gel and the drugs 
diffuses from this phase through the control membrane. Most drugs exist in stable 
protonated form, nitreous bases, which exhibit poor permeation profiles through 
nonpolar epidermis. Therefore, drugs are prepared in nonprotonated liquid form or 
unstable solid state. Silicon oils and minerals, that are capable of dissolving drugs, have 
been used to fill the reservoir or gels containing the drugs have been used as reservoirs 
(Vasil’ev et al. 2001). In addition to this, to maintain a constant driving force for the 
mass transfer, drug is loaded to the reservoir over its saturation concentration.  
Hydrogels that are highly swollen, hydrophilic polymer networks have found 
various applications in biomedical applications. Several systems such as resin gels have 
been used as reservoirs and recently, cross-linked poly(ethylene glycol) (PEG) networks 
are evolved as reservoirs for delivery of proteins via transdermal route. Thacharodi and 
Rao (1995) reported permeation controlled transdermal drug delivery systems using 
chitosan. Studies on propanolol chloride delivery systems using various chitosan 
membranes with different cross-link densities as drug release-controlling membranes 
and chitosan gel as the drug reservoir was performed. In vitro released profiles showed 
that devices constructed with chitosan membranes released propanolol chloride in a 
reliable and reproducible manner, and the minimum release was observed at the 
maximum crosslinking density (Thacharodi and Rao 1995). In another study of 
Thacharodi and Rao, indicated the use of collagen-chitosan composite membranes as 
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membrane-permeation-controlled transdermal devices for the release of propranolol and 
nifedipine. Jain et al. (2003) has also used the system of glutaraldehyde crosslinked 
chitosan membranes for the release-rate control and chitosan gels for drug reservoir for 
transdermal delivery of diltiazem hydrochloride, which resulted in zero-order kinetics 
for the drug release. On the other hand, several commercial membranes with various 
properties have been attempted. 
Membrane is the crucial component of the drug delivery patch as it in direct 
contact with the skin and acts as the interface between the drug reservoir and the skin to 
give optimal control for the transdermal drug delivery (Stamatialis et al. 2002). In 
addition to the factors in the choice of polymers for the drug delivery systems and 
specific to transdermal applications, the membrane should be biocompatible to prevent 
skin irritation, it should have the control over the drug release (with lower drug 
permeability than skin) and it should have low drug adsorption. In case of iontophoresis 
applications membranes with low electrical resistance is also required for better 
utilization of the power source.  
For a transdermal patch, the total permeability of a drug through the membrane 
+ skin is expressed as (Flynn et al. 1974): 
 
skinmembtotal PPP
111 +=          (2.2) 
 
where membP and skinP  represents the permeability of the drug through the membrane and 
skin, respectively. The drug delivery is considered as membrane-rate controlled when 
skinmemb PP /  ratio is less than 0.2, and as skin-rate controlled when this ratio is larger than 
5. Between these values, the delivery rate is controlled by both skin and membrane 
(Baker and Kochinke 1989).  
Drug flow through the membrane following zero-order kinetics is given by 
(Barker 1987); 
 
     
L
CDJ s⋅= γ
ε          (2.3) 
 
where J [mg/(cm2.s)] is the drug flow through the membrane, ε is the membrane 
constant (i.e., the ratio of the pore volume to the membrane volume), D [cm2/s] is the 
coefficient of drug diffusion through the pores, γ is the pore form factor (i.e.,  the ratio 
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of the molecular path length in the pores to the membrane thickness, Cs [mg/cm3] is the 
saturated drug solution concentration in the reservoir and L [cm] is the membrane 
thickness. Drug release from the membrane is assumed to be constant since Cs is 
constant until the overload is exhausted (zero-order kinetics) while it is provided the 
membrane properties remain unchanged during the transdermal system functioning.  
For a continuous membrane, the drug release from the transdermal system is 
described by Fick’s Law 
 
sPCL
CKDJ =∆=          (2.4) 
 
where J is the transdermal drug supply rate, K is the coefficient of drug distribution 
between the system and the membrane, D is the coefficient of drug diffusion in the 
matrix, ∆C is the gradient of the drug concentration between the system and blood, L is 
the epidermis thickness, Cs is the saturated drug solution concentration in the reservoir 
and P is the permeability of the membrane.  
 The matrix systems offer a simplified case for the design of transdermal 
therapeutic systems. In matrix systems, the drugs are dissolved and dispersed in material 
of the system so that an appropriate matrix diffusion profile determining the delivery 
rate of the drug molecules from the system is handled (Conaghey et al. 1998). The 
maximum drug diffusion (release) time depends on the matrix/membrane thickness, 
drug concentration, and the skin permeability for the given drug. These facts reveal that 
transdermal systems can be controlled by changing the matrix/membrane thickness and 
composition (drug concentration and limiting solubility), whereas manipulation can be 
handled by implying structural changes during the preparation of these materials.  
For the matrix type systems with assumed overload, the flow rate J [µg/(cm2.s)] 
at a current time instant T is given by the Higushi equation: 
 
T
DCMJ s
2
0=          (2.5)  
 
where M0 is the initial drug content in the transdermal system. As can be evaluated from 
the system, these systems do not obey stationary kinetics. 
Transdermal patches comprising matrices of PEG/Vaseline oil and 
PEG/Poly(vinyl alcohol) (PVA), commercialized with the name ‘Percutens’, carrying 
 
16
various drugs has been exploited (Vasil’ev et al. 2001). Nicotin loaded cross-linked ion-
exchange resins for both passive and iontophoretically assisted transdermal delivery 
systems (Conaghey et al. 1998), polyacrylamide and p-HEMA hydrogels for the 
transdermal release of protein/peptide drugs (Banga and Chien 1993) were attempted. 
There are several studies representing the ongoing research on this area such as matrices 
of Eudragit L(or E)-100/PVP and Eudragit L(or E)-100/PEG for diltiazem 
hydrochloride (Jain et al. 2003). In this study, diltiazem release was higher at the higher 
contribution of the hydrophilic polymers. Fractional dissolution of hydrophilic polymers 
in the matrix led to formation of gelaneous pores, which decreased the mean diffusional 
path length of the drug molecules to release into the diffusion medium. It has been 
reported that the simplest type of matrix patches contains a drug dissolved in an 
adhesive that is applied to an impermeable backing membrane. The reported studies 
include salicylic acid and chlorpheniramine maleate dissolved in a polymethacrylate 
amino ester copolymer matrix, lidocane and ketoprofen in acrylic/rubber 
(polyisobutylene) copolymers (Vasil’ev et al. 2001).  
Studies performed up to date show that hydrophilic matrices and membranes are 
more effective than hydrophobic ones in transdermal drug delivery systems. 
Hydrophilic matrices are also preferred for iontophoresis applications since hydration of 
the system is crucial for this application to allow the passage of the ions. The use of 
water-soluble polyelectrolytes as constituents of the hydrogel matrix in the formation of 
iontophoretic patches have been signified in the light of these findings (Kupperblatt et 
al. 1999). Electro-responsive or electrically stimulated pH sensitive polyelectrolyte 
membranes and hydrogels such as chondroitin 4-sulphate hydrogels (Jensen 2002), 
PMMA polyelectrolyte membrane (Grimshaw 1990) have been suggested to be 
promising for the iontophoretic delivery of large charged macromolecules such as 
proteins and peptides (Kost and Langer 2001). Such polyelectrolyte membranes may 
enhance the iontophoretic drug delivery by several mechanism such as enhanced 
membrane permeability due to electrically and chemically induced swelling, 
electrostatic partioning of the charged solutes into the membrane, electroosmotic 
augmentation of solute flux within the membrane or electrophoretic augmentation of 
solute flux within the membrane (Grimshaw et al. 1989).  
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2.3. Polyelectrolyte Complexes (PEC) 
 
2.3.1. General Aspects 
 
Macromolecular complexation of different polymers are formed by various 
intermolecular interactions, such as hydrogen bonding, Coulomb forces, Van der Waals 
forces, transfer forces, and hydrophobic forces. According to the nature of the 
dominating interactions, the complexes are named as polyelectrolyte complexes 
(sometimes called coacervate complexes), hydrogen-bonding complexes or charge-
transfer complexes (Peniche et al. 2003, Dumitriu and Chornet 1998). In case of 
polyelectrolyte complexes, electrostatic interactions play the major role in determining 
the mixed polymer behaviour. Secondary binding forces such as hydrogen bonding or 
covalent bonding may also participate in the formation.  
Polyelectrolytes are macromolecules carrying a relatively large number of 
functional groups that either are charged, or under suitable conditions can become 
charged. The molecules can exist as polyanions or cations, since the net charge of the 
macromolecules depends on the functional groups, which may be either positively or 
negatively charged, or both (Şimşek-Ege et al. 2002). One of the most interesting 
features of polyelectrolytes is their ability to form stable complexes as a result of ionic 
interactions. Therefore, Coulumbic interactions between polyelectrolytes may be either 
repulsive or attractive depending on whether the electrical charges are of the same or 
opposite sign. On the other hand, the interactions may be either short-ranged (weak) or 
long-ranged (strong) depending on the degree of ionization and the polyelectrolyte 
concentration. Therefore, the overall electrostatic interactions, which depends on the 
physicochemical character (e.g. charge density and molar mass), concentration and ratio 
of the polymers, is very sensitive to variations in pH and ionic strength of the 
complexation medium. Furthermore, temperature, shear and pressure can affect the 
formation and stability of the complexes (Dickinson 1998, Weinbreck et al. 2003a).  
Complexation between two oppositely charged polyelectrolyte can lead to: 
• Precipitation (insoluble solid phase) 
 Driven by charge neutralization on hydrophobic polymers 
 Driven by macro-aggregate formation 
• Coacervate formation (dense liquid phase) 
• Soluble Complexes 
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The formation of complexes occurs by a step-wise process. Initially, a primary 
complex is formed with respect to Coulumbic interactions. Second step implies the 
formation of new bonds and/or correction or the distortion of the polymer chains 
resulting in a new conformation of the complex. Finally, secondary complexes 
aggregate mainly due to hydrophobic interactions at the third stage (Figure 2.5).  
 
 
Figure 2.5. Schematic presentation of the aggregation of the PECs 
(Source: Kokufuta et al. 1979). 
 
Most pronounced secondary complex conformations are ladder or scrambled egg 
models. The resulting structures of polyelectrolyte complexes are explained by two 
models, ladder and scrambled egg, in the literature. “Ladder-like structure” refers to 
complex formation on a molecular level via conformational adaptation, whereas the 
“scrambled egg model” denotes the incorporation of high number of chains into a 
particle. PEC formation between polyions with weak ionic groups may lead to soluble 
complexes with a ladder-like structure. However, in most applications of PEC formation 
results in highly aggregated systems obeying the scrambled egg model (Dautzenberg 
2000). On the other hand, in highly diluted solutions quasi-soluble particles on the 
colloid level are formed.  
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Polyelectrolyte complex formation is widely used for the preparation of 
membranes, gels, films, etc., with special properties, microencapsulation of biological 
components, isolation and fractionation of proteins, enzyme immobilization, and 
controlled delivery, but also as carriers for proteins and nucleic acids, supports for 
catalysts, implants for medical use and food ingredients (Dautzenberg 2000, Schmitt et 
al. 1999). The use of natural and/or synthetic polyelectrolytes as building blocks, 
preparation techniques and the resulting properties of the complexes characterize the 
potential end uses of these systems.  
Complex formation between synthetic polyelectrolytes such as poly(sodium 
styrene sulfonate) and polyvinylbenzyl trimethylammonium chloride have been studied 
extensively. The membranes produced by the specified PEC system have been found 
promising for desalination of seawater, dialysis, ultra-filtration and purification of 
aqueous solutions containing colloids, micro- and macroparticles. There are numerous 
synthetic polyions and polycations employed to polyelectrolyte complexation. 
Recently, the use of natural polymers in polyelectrolyte complexes for 
encapsulation of drugs, proteins and viable cells, and stimuli responsive systems has 
received much attention because of their biocompatibility. There are any kinds of 
natural polyelectrolytes such as proteins and polysaccharides to be used for 
complexation. Polysaccharides are natural polyelectrolytes whether anionic or cationic 
and proteins are polyampholytes (polymers containing both positively and negatively 
charged segments).  
Chitosan, a biocompatible and biodegradable polysaccharide, has been utilized 
in several studies as polycationic partner in PEC formation. Chitosan based PEC with 
natural polymers such as sodium alginate, κ-carrageenan, heparin, pectin, xanthan or 
synthetic polymers such as poly(acrylic acid), polystyrene sulfonate have been reported. 
Chitosan-sodium alginate membranes were proposed for wound-dressing material with 
respect to its noncytotoxicity, capability of supporting cell proliferation and pH-
dependent water uptake, whereas chitosan-xanthan complexes as reported to be an 
appropriate drug delivery vehicle with enhanced swelling characteristics. 
Protein-protein interactions were also investigated in terms of polyelectrolyte 
complexation. Macromolecular interactions between oppositely charged proteins led to 
enhanced functional properties of including foaming, aggregation phenomena and 
gelation. The parameters effective through enhancement were reported to be 
concentration of each protein in the mixture, pH and ionic strength of the solution. The 
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complexation systems of proteins with synthetic polyelectrolytes such as heparin/PVA 
were also studied.  
Protein-polysaccharide complexation, which is also called complex 
coacervation, has suggested as a special case of polyelectrolyte complex formation and 
it is evidenced by coacervate formation. Besides their biotechnological and biomedical 
utilization, the detailed information and the structure of the complex coacervates can 
also be helpful to understand the mechanisms of complex biological processes as the 
formation of polymeric complexes of proteins and polysaccharides simulate the 
intermolecular interactions during the formation of biological systems. For this reason, 
proteins and polysachharides complexes can be used in products that are directly contact 
with the living organism with the less allergic risks compared with synthetic polymers 
since they are of biological origin (Schmitt et al. 1998). Additionally, certain properties 
of protein/polysaccharide coacervates were found to be better than those of the pure 
protein and pure polysaccharide (Schmitt et al. 2000), and their complexation has been 
found very promising as constituents of biomaterials with respect to enhanced 
physicochemical properties, film-forming capability and environmental stability. 
However, further work on these complexes is required to make up the global 
characterization of the formation, stability, structure and techno-functional properties of 
these complexes.  
 
2.3.2 Protein-Polysaccharide Complexation 
 
Protein-polysaccharide interactions have been investigated widely with respect 
to its promising applications in biotechnological and biomedical areas as well as its 
biological aspects. In living organisms, proteins and polysaccharides can be naturally 
associated to maintain cell integrity in the formation of membranes, and participate in 
cell division through histone/DNA complexes or enzyme catalysis, whereas they can be 
incompatible as they involve in cell partition. 
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Figure 2.6. Main trends in the behavior of protein/polysaccharide mixtures 
(Source: WEB_2 2005). 
 
The mixtures of protein and polysaccharides generally lead to phase separation 
due to phase separation through thermodynamic incompatibility or complex 
coacervation (Turgeon et al. 2003) as illustrated in Figure 2.6. As the protein and 
polysaccharide are incompatible, they repel each other and a thermodynamic phase 
separation, which is also called segregation or depletion interaction, occurs. Phase 
separation results in a mixture with two phases, one is rich in protein and one is rich in 
polysaccharide. A diluted and non-reactive biopolymer mixture of proteins and 
polysaccharides may also exhibit co-solubility. On the other hand, if they attract each 
other through electrostatic interactions, the biopolymers associate excluding the solvent 
from their vicinity. This gives rise to the formation of protein/polysaccharide 
complexes. Associative phase separation of the mixture results in two phases: the lower 
phase containing the protein/polysaccharide complex and the upper phase containing 
mainly the solvent.  
Coacervation describes the phase separation of a liquid polymer rich-phase from 
a macromolecular solution, representing the separation of two liquid phases in a 
colloidal system. The phase more concentrated in colloid component is the coacervate 
and the other phase is the equilibrium solution (de Kruif et al. 2004). In the mixture, 
electrostatically attracted and bound complexes can also be either soluble or insoluble. 
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The coacervate layer occurs as the insoluble complexes concentrate in liquid coacervate 
droplets followed by the further coalescence and phase separation (Figure 2.7).  
 
 
 
Figure 2.7. Schematic representation of phase separation by complex coacervation 
(Source: WEB_2 2005). 
 
The complex coacervation was discovered by Tiebackx in 1911, and the term 
‘coacervate’ was first introduced by Bungenberg de Jong (1949). Coacervate was 
derived from the Latin word “acervus” which means aggregation, and “co” means 
together. Thus, “coacervation” denotes the union of the colloidal particles. By colloidal 
particles, de Jong signified the liquid droplets, primarily induced by demixing (Figure 
2.8). The word ‘coacervate’ was specifically preferred instead of precipitate to explain 
this phenomenon since the complex remains liquid, rather than forming a precipitation 
(de Kruif and Tuinier 2001). The detailed study of Bungenberg de Jong (1949) revealed 
under which conditions complex coacervation occurred, such as pH, ionic strength, 
polymer concentration, polymer ratio, and temperature. Simple coacervation was 
described in this study as the coacervation process involving only one biopolymer. It 
occurs by the excluding the solvent from a hydrophilic colloid by introducing a 
competing hydrophilic substance, such as salt or alcohol, to the solution medium. This 
is also called as ‘salting out’ and results in simple coacervation (Peniche et al. 2003). 
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Figure 2.8. The coacervate droplets that have partially spread over the surface of the 
microslide and coaleasced with each other. This picture was reproduced 
from the study of de Jong and Kruyt (1929) 
(Source: WEB_2 2005). 
 
The ternary system (two biopolymers and a solvent) of coacervation is 
characterized by a one- or two-phase equilibrium state. Complexation depends on 
biopolymer-biopolymer and biopolymer-solvent interaction forces (enthalpic effects), 
and dominantly on the size and structures of biopolymers (entropic effects) (Schmitt et 
al. 1999). Therefore, the formation of these biopolymer complexes governed by 
electrostatic interactions represents the key parameters of charge density, geometry 
(shape and flexibility of charge distribution), swelling, counterion hydrophilicity, and 
screening (Weinbreck et al. 2004) that explains the strong dependency on pH ad ionic 
strength of the medium.  
The knowledge of protein/polysaccharide complexation inspires the researches 
to build biological systems on this phenomenon. For instance, DNA-gelatin 
nanoparticles formed by salt-induced complex coacervation of gelatin and plasmid 
DNA have been used for the development of a novel system for gene delivery. Besides 
the fundamental interest on biological phenomena, complex coacervation has been used 
in the fields of pharmaceuticals, medicine, foods, cosmetics, etc. Complexation has been 
studied in the purification and recovery of the macromolecules (e.g. protein) on the lab 
scale and offered several advantages such as high removal levels and more thermal 
stability through complexation. Microencapsulation based on the ability of the 
coacervates to form a coating around sensitive materials (e.g. drug particle or an oil 
droplet containing flavors) has been investigated extensively and commercialized. 
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Promising results on the gelatin/gum arabic microcapsules had led to extensive 
investigations on this system and have been proposed applications in the fields of 
pharmacy, cosmetics, carbonless copy paper production, biotechnology, and food 
ingredients. Addition to this system, milk protein/xanthan gum system was also 
suggested as a food ingredient, e.g. fat substitute and meat replacer (Chen et al. 1989).  
The biodegradability of the complexes offers the use of the complexes as 
biopackaging or edible food packages based on the film formation properties of the 
complexes. It has been reported that the coacervate films of sodium caseinate/wheat or 
starch corn displayed good mechanical and gas barrier properties. On the other hand, 
polyelectrolyte films produced by the chitosan/alginate coacervates have represented 
good biocompatibility and found promising in biomedical applications. There have been 
several studies indicating the potential of protein/polysaccharide complexes as 
constituents in the production of biomaterials such as wound dressings, sutures, blood 
substitutes or artificial prostheses, grafts or vessels.  
 
2.3.3. Models on Formation of Coacervate Systems 
 
When the protein and polysachharide dispersions are mixed together at a pH and 
weight ratio where interactions are strong, they can form complexes. However, it has 
been reported that, it is a challenging work to follow the very fast initial events and to 
study the different structural transitions. To overcome this drawback, such mixtures are 
firstly prepared at a pH where no interactions take place, and then acidification is 
performed to focus the specific pH range to determine the potentiometric conditions 
where interactions occur. Upon lowering the pH, the interpolymeric complexes occur at 
a critical pHc value. The critical pH value can be observed above isoelectric point (IEP) 
of protein due to heterogeneous charge distribution and/or randomly charged patches on 
the protein surface. The very first small variations in turbidimetric signals are attributed 
to this formation of soluble intrapolymeric complexes. Further decrease of the pH leads 
to coacervation at pHφ. By analogy to the colloidal systems (Leisner and Imae 2003), at 
the critical pHφ, the coacervates interact together to form a fully percolated system that 
phase separates from the solvent. The pHφ is generally detected by a more or less 
‘strong’ increase in system turbidity.  
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Figure 2.9. Intrapolymer (A) and interpolymer (B) complexes  
(Source: de Kruif et al. 2004). 
 
Consequently, for all systems studied, two major structural transitions in the 
mechanism of complexation have been observed. Thus, the process of complex 
formation was explained by 3-step formation of coacervates 
1. intrapolymeric complexes at pHc 
2. Interpolymeric soluble and insoluble complexes 
3. insoluble complexes and macroscopic phase separation at pHφ 
(coacervation or precipitation) 
There are only a few studies on the structure of the soluble complexes, 
coacervate droplets and coacervate phases that occur during the transitional formation 
of complexes. The recent light-scattering technique based study of Leisner and Imae has 
represented the structure of the complexes through the transitions of interpolymeric 
complexes to coacervates, for the first time. Proposed model, describing the subsequent 
associative micro- and macrophase separation, is schematically shown in Figure 2.10.  
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Figure 2.10. Schematically proposed model for coacervate formation 
for a protein/polysaccharide mixture  
(Source: Leisner and Imae 2003). 
 
The model describes the coacervation mechanism with respect to protonation of 
the protein that occurs below its isoelectric point. Independent protein and 
polysaccharide (1) interact attractively to form transient ‘monomolecular’ 
interpolymeric complexes (2), which remains highly negatively charged but with 
positively charged patches localized at the side of the protein away from the chain. By 
this mean, the protein cation can form transient crosslinks between two polysaccharide 
chains and this formation constitutes the first step to multimolecular interpolymer 
complexes (3). This is followed by aggragation to microgels (4) that is limited by the 
net charge of the biopolymers. By further protonation of the protein almost neutral high 
molecular weight interpolymer complexes (5) with partially collapsing center is formed.  
As the critical size/charge ratio for attraction between microgels is reached, microgels 
stick together to form a microgel cluster (6). However, a complete collapsing is 
hindered due to overcharging or steric hinderence. After a time consuming 
swelling/deswelling process of the microgels for cooperative coupling, eventually, a 
hierarchically branched intramolecular structure (7) with the charge stabilization occurs. 
The equilibrium would be reached at a macroscopic phase separation to the coacervate 
(8) through coagulation of the stabilized microgel clusters (7), leaving an upper phase 
with only sporadically clustered microgels (5). As a consequence, coacervates are 
reported as randomly branched gels with a sponge-like morphology and compact and 
smooth microgel homogeneities larger than 20 nm.  
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Various physico-chemical parameters influence the electrostatic interactions 
between two biopolymers and thus the complex formation. For instance, pH plays a key 
role in the strength of electrostatic interaction as it determined the charge density of 
both polymers. Moreover, the ionic strength of the system has a significant effect on 
coacervation since it has been reported that addition of salt created screening of the 
interactions between two components. Table 2.2 chronologically represents the research 
on the formation of protein/polysaccharide systems based on these parameters by 
several experimental methods such as turbidimetric titration, dynamic and static light 
scattering, viscosimetry, etc. 
Complex coacervation systems have been studied extensively through the 
investigations on complexation of the proteins with both polysachharides and synthetic 
polyelectrolytes. The work reported in this thesis focuses on the complex formation of 
protein/polysaccharide mixtures.  
The trend nowadays, to replace the protein and polysaccharide components by 
other biopolymers to form complexes offering complexation mixtures that may result in 
novel properties and application areas. Among several biopolymers, silk fibroin, as a 
fibrous protein, and hyaluronic acid, as a widely used polysaccharide, has not been 
worked on with respect to coacervate complexation and the potential application of the 
material processed through complexation. The work reported in this thesis focuses on 
the complexation of silk fibroin ad hyaluronic acid and its potential applications in the 
fields of biotechnology and biomedicine. The following subsections represent the 
extensive information on these natural biopolymers. 
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Table 2.2. Factors studied for some protein/polysaccharide systems studied in literature.  
REFERENCES SYSTEMS EXPERIMENTAL TECHNIQUES PARAMETERS 
Bungenberg de Jong 1949 Gelatin / GA Light microscopy, Viscosity,  Turbidity, Phase diagrams 
pH, Pr:Ps*, Cp, ionic 
strength,  
types of ions 
Burgess and Carless 1984 Gelatin / GA Microelectrophoretic mobility pH, Pr:Ps, pl of gelatin, ionic strength 
Burgess and Carless 1985 Gelatin / Gelatin 
Microelectrophoretic mobility,  
Preparation of gelatin 
microcapsules 
pH, ionic strength, 
temperature,  
gelatine concentration, 
Pr:ps, time, drug 
content 
Burgess and Carless 1986 Gelatin / Gelatin 
Microelectrophoretic mobility  
Coacervate yield determination  
Photon correlation spectroscopy 
pH, ionic strength, 
temperature, time,  
treatment of gelatin 
solutions 
Burgess 1990  Gelatin / GA BSA / GA 
Microelectrophoretic mobility 
Dry coacervate yield 
determination 
pH, ionic strength, Cp, 
time 
Burgess 1991  BSA / GA 
Microelectrophoretic mobility 
Dry coacervate yield 
determination 
pH, ionic strength, Cp 
Burgess 1994  Gelatin / GA BSA / GA 
Microcapsule production 
Particle size stability 
Scanning electron microscopy 
pH, Pr:Ps, stirring 
speed, time 
Girard et al. 2002 
β-lg / Pectin  
(low- and high- 
methylated) 
Potentiometric titrations 
Determination of the quantity of 
â-lg complexed to pectin 
(ultrafiltration) 
Pr:Ps, pH, NaCl, urea, 
temperature 
Girard et al., 2003  
β-lg / Pectin  
(low- and high- 
methylated) 
Isothermal titration calorimetry 
(binding constant, stoichiometry, 
enthalpy, entropy) 
Overlapping binding site model 
Pr:Ps, time 
Plashchina et al. 2001 
Faba bean 
legumin / 
chitosan 
Ultraviolet spectroscopy, 
Viscometry, Calorimetry,  
Turbidimetric titration, Surface 
tension, Emulsion stability 
Pr:Ps, ionic strength, 
pH 
Sanchez et al. 2002 β-lg / GA 
Confocal laser microscopy, small 
angle static light scattering 
(SASLS), Time resolved SASLS, 
Turbidity 
Time, Pr:Ps = 1:1 and 
2:1 
Schmitt et al. 2000 β-lg / GA 
Confocal scanning laser 
microscopy,  
Diffusing wave spectroscopy 
Pr:Ps, â-lg with or 
without aggregates,  
time, Cp = 1% or 5%, 
pH 4.2 or 4.5 
Tuinier et al. 2002 
Casein 
micelles / 
pectin 
Dynamic light scattering 
Adsorption measurements 
Renneting experiments 
Time, concentration in 
GDL,  
pectin concentration, 
percentage of renneting 
Weinbreck et al. 2004 Whey  Protein/ Gum Arabic 
 
Small Angle X-Ray Scattering 
Turbidimetric titration 
 
Pr:Ps, ionic strength, 
pH 
 
*Pr:Ps denotes the protein/polysaccharide weight ratio in the biopolymer mixture.  
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2.3.3.1. Silk Fibroin 
 
Silks are protein polymers that are biosynthesized by the epithelial cells within 
the glands of silkworms and spiders. Silk proteins are secreted into the lumens of these 
glands and then spun into fibers (Altman et al. 2003). The most abundant and 
extensively characterized silk is produced by the domestic silkworm Bombyx mori. Silk 
synthesized by B. mori consists of two kinds of protein, sericin and fibroin. Fibroin is 
the structural fibrous protein and constitutes 70% of the intact silk, and sericin is the 
water-soluble glue-like protein that surrounds and binds the fibroin fibers (Magoshi et 
al. 1996). Sericin can be easily removed from the silk fiber by a traditional degumming 
process (treatment of fibers with an alkali salt solution at ∼100 °C), and hence silk 
fibroin is also called degummed silk (sericin-free silk fiber). 
Silk has been commercially used as surgical sutures for decades and as a source 
of textile-grade fibers for centuries. The attractive properties stem from the physical 
chemistry of silk since this protein is made up of almost all fiber (Zhou et al. 2001). 
Recently, interest has been concentrating and dramatically increasing on the use of 
several processed forms of the solubilized silk fibroin in biotechnological materials and 
biomedical applications. On the other hand, fibroin is widely used in cosmetics and also 
suggested as a pharmacological agent or as a food additive. Silk fibroin contains about 
6% essential amino acid and in addition to this, it lowers the blood glucose level with 
respect to its alanine content and enhances the alcohol metabolism of the liver with 
respect to its glycine content (Lue et al. 1993). 
A fibroin molecule is composed of a heavy chain and a light chain connected by 
a disulfide linkage. The larger heavy chain having a molecular mass of ∼350 kDa is 
composed of 12 repetitive domains that constitutes crystalline ordered clusters of 
oligopeptides Gly-Ala-Gly-Ala-Gly-Ser, [Gly-Ala]n-Gly-Tyr and [Gly-Val]n-Gly-Ala (n 
= 1-8). These domains are separated by 11 amorphous regions in which peptides are 
mainly in the sequence of Gly-Ala-Gly-Ser and Gly-Ala-Gly-Ala-Gly-Ser (Hossain et 
al. 2003, Yamada et al. 2001). It is mostly reported that the primary structure of silk 
fibroin is characterized by the crystallizable repeating sequence of six amino acidic 
residues (Gly-Ala-Gly-Ala-Gly-Ser)n since this simple and regular unit forms ∼70% of 
the amino acid sequence. The heavy chain of the silk fibroin comprises mostly 
hydrophobic amino acid residues, whereas the hydroxyl residues of Ser and Tyr along 
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the chain provide affinity to water. The charged amino acid residues, glutamic acid 
(Glu) and aspartic acid (Asp), that reside in two chain ends and in the amorphous region 
illustrate the polyelectrolyte nature of the heavy chain. Light chain of the fibroin with a 
molecular mass of ∼25 kDa has a non-repetitive sequence including higher contents of 
charged amino acids, and it is hydrophilic in nature. However, the light chain has a 
minor contribution in the fiber characteristics (Hossain et al. 2003, Zhou et al. 2001).  
 
 
Figure 2.11. Secondary structure of SF 
(Source: WEB_3 2005).  
 
The major secondary structures of silk fibroin are described as two different 
conformations: silk I (α-helix, random coil) and silk II (β-sheet). Silk I is the water-
soluble structure of fibroin that mimics its liquid structure in the silkworm glands. Silk 
II is the well-oriented anti-parallel β-sheet conformation of the water-insoluble spun 
fibers as shown in Figure 2.11. In this conformation, the polypeptide chains are aligned 
and adjacent chains are connected with hydrogen bonds (>C=O⋅⋅⋅HN<) (Yamada et al. 
2003). The lately reported silk III structure of fibroin represents its surfactant behaviour 
and builds at the water-air interface in thin films (Valuzzi et al. 1999).  
Numerous researchers have reported that the conformational change, from silk I 
to silk II, during the fiber spinning of the silkworm is induced as a result of the applied 
shear and elongation stresses. The silk fibroin fibers with β-sheet confirmation establish 
sufficiently strong intermolecular hydrogen-bonding, which prevents the separation of 
molecules, and hence their dissolution to pure water. However, the fibers are easily 
redissolve in water with very concentrated neutral salt solutions (LiBr, LiSCN, CaCl2) 
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without inducing hydrolytic degradation (Tsukada et al. 1994). By the contribution of 
high concentration of ions, intermolecular interactions are screened and a pathway for 
dissolution is created. Following dialysis after the dissolution provides the preparation 
of the salt-free fibroin solution.  
 
 
Figure 2.12. The relation between conformation, quenching or casting temperature and 
concentration of silk fibroin  
(Source: Magoshi et al. 2000). 
 
Aqueous fibroin solution, which is also called regenerated silk fibroin (RSF), is 
environment-friendly and used in various applications. RSF is of interest as it represents 
a good starting material for the preparation of different forms of materials by the 
application of various processing techniques. Furthermore, the easily controlled 
characteristics of the end product by changing the processing conditions or by applying 
post-processing treatments represent the reason of this interest. The silk I structure is 
metastable and easily changes to the silk II, and therefore the solubility and the 
mechanical charateristics of fibroin-based materials can be controlled by utilizing the 
conformational change of fibroin.  Adjustable processing conditions can be summarized 
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as solution concentration, solution temperature, quenching temperature, drying 
temperature, drying time, presence of an electric field, pH and presence of certain 
enzyme (Putthanarat et al. 2002). Figure 2.12 shows the change of the conformation of 
the casted aqueous silk fibroin samples by quenching or casting temperature and the 
concentration of silk fibroin (Magoshi et al. 2000). Furthermore, the influences of initial 
protein concentration, temperature and pH have been previously designated with respect 
to high hydrogelation tendency of aqueous SF solutions. This brings a material option 
for preparation of biomaterials in the form of hydrogels.  In aqueous solution at neutral 
pH, dissolved fibroin takes the random coil structure (Nemoto et al. 1999).  It has been 
reported that the random coil to silk I transformation occurs at pH > 6 as the negative 
charges provide a strong repulsive component to protein-protein interactions. As the pH 
is lowered, this repulsion decreases and allows a closer approach of neighboring 
molecules. This increases the potential for the formation of a β-sheet structure through 
hydrophobic interactions with a simultaneous increase in viscosity of the solution 
(Hossain et al. 2003). At the pH values closer to the isoelectric point (IEP) (IEP = 3.8-
3.9) of fibroin, especially pH < 4.5, transition from random coil to silk II occurs, and 
concurrently, gelation of the silk fibroin molecules accelerates. Such an observation can 
be interpreted as a typical behaviour of proteins that aggregate near their isoelectric 
points (Kim et al. 2004). The gelation time of fibroin decreases with increasing the 
initial concentration of fibroin and temperature, and gelation is reversible, if its 
exposure to acidic conditions is brief. Otherwise, gelation is irreversible since the 
hydrogen bonds are too strong to be broken at mild conditions (Terry et al. 2004, Kang 
et al. 2000). 
If the end product is a fibroin-based film, casting surfaces are also stated to be 
effective. It was reported that casting onto different surfaces such as polyethylene, glass, 
polystyrene, platinum wire may influence the conformation. As the fibroin-based 
material is processed, numerous reports notice the possibility of further treatments on 
the material to improve its collective properties. The widely applied post-processing 
treatments are stretching, heating and immersion in hydrophilic polar solvents (e.g. 
methanol). Rate and ratio of stretching, heating temperature, concentration of the 
solvent and their application time are used to control the molecular conformation, and 
hence the properties of the resulting fibroin-based material such as solubility and 
morphology (Putthanarat et al. 2002, Nam et al. 2000). 
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Among the possible processed forms of the silk fibroin, there has been a 
growing interest in fibroin films and membranes within the last few decades. Silk 
fibroin has good film-forming capability, and amorphous, water-soluble silk fibroin 
films casted from aqueous regenerated fibroin solution can be made insoluble by means 
of simple physicochemical treatments as they undergo transitions from random coil to 
β-structure. The insoluble silk fibroin films are soft and flexible in wet state and it was 
suggested that water in the films serves as a plasticizer (Minoura 1996). However, these 
films suffer from poor tensile strength in dry state, in non-aqueous environments or on 
exposure to ambient air, and hence, they are very brittle and unsuitable materials for 
practical use. Therefore, the physical properties of silk films require improvement by 
physical or chemical modification. Several studies highlighted that the collective 
properties of these films can be improved by polymer blending as an effective and 
economical technique. Silk blends have been extensively studied as binary systems with 
respect to film formation by many researchers. Blends with synthetic polymers such as 
poly(ethylene oxide) (Jin et al. 2004), polyacrylamide (Freddi et al. 1999), poly(vinyl 
alcohol) (Tsukada et al. 1994, Yamaura et al. 1990) , poly(ethylene glycol) (Gotoh et al. 
1997), polyallylamine (Arai et al. 2002) or with natural polymers such as chitosan 
(Rujiravanit et al. 2003, Park et al. 1999, Chen et al. 1997), cellulose (Freddi et al. 
1995), sodium alginate (Liang and Hirabayashi 1992) have been studied to improve the 
mechanical or thermal or membrane properties of silk films. Silk fibroin/PEO blend 
films showed improved mechanical properties and predictable surface morphology 
based on the based on the PEO content. Thermal and mechanical properties of 
fibroin/polyacrylamide blend films represented significant improvements, whereas 
silk/PVA blend films showed increased permeability to neutral salts. By blending with 
cellulose, films with excellent elastic behaviour was prepared and porous cellulose 
membranes were produced by dissolving the silk in 10% NaOH. In case of chitosan 
addition, conformational transition to silk II is induced and resulted in increased 
crystallinity and mechanical strength in the fibroin/chitosan blend films. Blends may 
have included crosslinking agents such as glutaraldehyde (Rujiravanit et al. 2003), (1-
ethyl-(3-3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) (Bayraktar et al. 
2005) or cosolvents such as water, formic acid (Park et al. 1999) and acetic acid (Chen 
et al. 1997).  
Consequently, silk fibroin, as a representative fibrous protein, takes the attention 
of various scientists and technologists as a promising resource with respect to its unique 
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mechanical properties, the versatility in processing, as well as its biocompatibility, 
biostability and slow rates of biodegradation (Sofia et al. 2001, Perez-Rigueiro et al. 
1998). Fibroin aqueous solution reformed into gel, sponge, powder, film and membrane 
with given properties and environmental stability pointed out its applicability in the 
production of biotechnological and biomedical materials. In addition to these, the 
minimal inflammatory reaction of these silk-based biomaterials supported its suitability 
as scaffolds for tissue engineering, cell culturing applications or implant materials (Fini 
et al. 2005, Meinel et al. 2005, Gotoh et al. 2004). Fibroin hydrogel have been found 
potentially useful as bone replacement material as it improves bone healing and 
maturation (Fini et al. 2005). Fibroin membranes and fibroin/PVA composites have 
been proposed for immobilized matrix of enzymes for the second generation of 
biosensors (Zhang 1998, Qian et al. 1996). It has been also reported that silk fibroin 
membranes have high-dissolved oxygen permeability and water-vapor permeability in 
the wet state, similar to that of human skin, which suggest the potential of fibroin in the 
development of wound dressing artificial skin, soft contact lenses with high oxygen 
permeability, artificial corneas. These promising applications represent fibroin as a soft-
tissue compatible biopolymer (Minoura et al. 1990).  
As a result of benefits of being nontoxic, biocompatible and biodegradable, 
fibroin has been suggested to be used in drug preparation and in drug delivery systems. 
Fibroin gels have been proposed for oral dosage form (Hanawa et al. 1995), membranes 
as controllable medicine-releasing carriers (Li et al. 2001) and fibroin/chitosan matrices 
for a transdermal drug delivery system (Rujiravanit et al. 2003). Chen at al. (1994) 
studied the transport of pharmaceuticals through silk fibroin membranes and reported 
that fibroin membrane as an amphoteric ion-exchange membrane composed of both 
weak acidic and basic groups represents pH-dependent drug permeability. It has shown 
that transport rate of penetrant through a fibroin membrane can be controlled by 
changing the charge-state of the membrane. Membrane permeability can be 
significantly influenced since the effective charge density of membranes composed of 
fibroin molecules can change with pH, if pharmaceuticals can also be ionized with pH 
(Chen et al. 2000). Therefore, it has been stated that fibroin membranes are considered 
to have great potential for controlling the transport of pharmaceuticals such as in drug 
delivery systems. 
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2.3.3.2. Hyaluronic Acid 
 
Hyaluronic acid (HA) is a naturally-occurring linear polysaccharide that is a 
copolymer of N-acetyl-D-glucosamine and D-glucuronic acid disaccharide units 
connected by regularly alternating β-(1→3) and β-(1→4) glucosidic bonds (Figure 
2.13). This endogenic biopolymer was discovered first by Meyer and Palmer (1934) and 
is present in the extracellular matrix of all higher animals as the only non-sulfated 
glucosaminoglycan (Šoltés and Mendischi 2003, Luo et al. 2000). Chosen by Meyer in 
1934, the name hyaluronic acid comes from hyaloid (meaning "vitreous") and uronic 
acid. The term hyaluronate refers to the conjugate base of hyaluronic acid. Because the 
molecule typically exists in vivo in its polyanionic form, it is most commonly referred to 
as hyaluronan (WEB_4 2005). 
HA is found in high concentrations during fetal skin development and it 
contributes to cell migration and differentiation, and it has been reported that HA is the 
first macromolecule to appear in the extracellular matrix during wound healing 
(Alexander et al. 1980). It is also called hyaluronan, as assigned by Balázs et al. (1986), 
and in some cases, hyaluronan is a major constituent of the mature tissues; as, for 
example in the vitreous of human eye, or in synovial joint fluid or it exists as an 
important component such in connective tissues (e.g. cartilage). Industrially, HA is 
obtained from animal tissue such as eyeball, umbilical cord, and it can be produced on a 
large scale by biotechnology as it is also present in the capsule of some strains of 
Streptococci. 
 
 
Figure 2.13. Chemical structure of hyaluronic acid  
(Source: Kim et al. 2003). 
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Under physiological conditions, HA is a polyanion ad its pKa value is estimated 
to be 2.9 (Šoltés and Mendischi 2003). The molecular weight of HA changes in the 
ranges from hundreds of thousands to several millions of Daltons and its extremely high 
molecular weight yield a highly viscous solution even at low concentrations such as 0.1 
wt%. In solution, HA chains assume an expanded ‘somewhat-stiff’ random coil 
conformation. The size of the HA ‘globule’ varies with pH and salt concentration as 
expected for a flexible polyelectrolyte (Cleland 1968). It has been reported by Gibbs et 
al. (1968) that at pH 2.5 the HA solutions were more elastic and exhibited a ‘paste-like’ 
nature on gentle shaking or stirring, which was attributed to a pronounced stiffening of 
HA chains. This was interpreted to occur as a result of a critical balance between the 
repulsive forces (provided by the ionized carboxyl groups) and the attractive 
interactions (electrostatic or hydrogen bonds originated) functioning between the 
molecular chain elements. In addition, Ghosh et al. (1993) indicated that at alkaline pH, 
HA gains a more compact, flexible random coil conformation as the hydrogen bonds 
taking part in the structural organization of HA chains are destroyed resulting in a large 
loss of the intrinsic stiffness.  
Unmodified hyaluronic acid has been found many applications owing to its 
unique viscoelastic nature. This lubricous biopolymer has been used for medical 
purposes for surgical treatments in ophthalmology as a viscoelastic biomaterial 
protecting ocular cells during surgery or in orthopedics for the treatment of joint disease 
through injection of the aqueous solution. Additionally, it is used in cosmetic 
applications to moisturize the skin with respect to its high water retention ability.  
Hyaluronic acid is also an attractive building block for novel biocompatible and 
biodegradable biomaterials with potential applications in drug delivery (Surini et al. 
2003, Luo et al. 2000, Simon et al. 1997) and tissue engineering (Park et al. 2002) and 
with proposed applications in the production of artificial blood vessel and artificial skin 
(Choi et al. 1999, Nishida et al. 1993). Such applications require 
modification/derivatization of HA since it is very soluble in water or in aqueous salt 
solutions and it has quick hydrolytic degradation in biological environment. By these 
means, the recent studies focus on the methods to tailor the physicochemical properties 
and in vivo residence time of HA to specific applications while keeping its excellent 
water absorptivity, intrinsic biocompatibility, biodegradability, and lack of 
immunogenicity thereof. Modified HA based biomaterials can be produced in the form 
of films, gels, sponges, composites, etc. 
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Crosslinking is one of the mechanisms used to make HA-based materials water-
insoluble. Many attempts has been proposed to prepare cross-linked gels of HA having 
reduced water solubility including 1,2,3,4-diepoxybutane in alkaline medium, divinyl 
sulfone in alkaline medium, formaldehyde, glutaraldehyde, dimetylolurea, 
dimethylolethylene urea, ethylene oxide, polyaziridine, polyisocyanate and water-
soluble carbodiimides. Among these reagents, relatively more biocompatible EDC, 
which has good solubility properties, has been widely used. It has been reported that the 
HA crosslinks are obtained by the intermolecular formation of ester bonds between the 
hydroxyl and the carboxyl groups in different molecules (Tomihata and Ikada 1997). 
Balazs et al. (1986) stated that crosslinked gels of HA can slow down the release of a 
low molecular weight substance dispersed therein but not covalently attached to the gel 
macromolecular  matrix. It was also reported that delayed and pulsatile release of 
protein-based drugs are found to be potentially useful through partially esterified HA 
membranes (Simon et al. 1997). In another study, crosslinked hyaluronic acid 
hydrogels, Figure 2.14, are reported to exhibit reverse swelling and drug release 
behaviour under applied electric field. When the electric field is applied, rapid 
contracted and deswelled due to partial protonation of the ionized polyelectrolyte 
network and the drug release was reduced and stopped. On the other had, when the 
current is switched off, the gel swells again and the drugs can diffuse out by the ‘pore’ 
mechanism (Tomer et al. 1995). 
 
 
 
Figure 2.14. Schematic depiction of crosslinked HA hydrogel 
(Source: WEB_5 2005). 
 
Another group of study represents crosslinked HA blends through both amide 
and ester bond formation including the binary systems of HA/PVA (Kim et al. 2003), 
HA/gelatin (Choi et al. 1999) and HA/collagen (Park et al. 2002). Crosslinking was 
applied to the systems through immersion in crosslinking agent solutions, or adding the 
HA backbone 
crosslinks 
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powder form or solutions of these agents into blend solutions. Crosslinked HA/PVA 
hydrogels showed an electrical and pH sensitive behaviour that can be utilized in drug 
delivery systems, whereas crosslinked HA/collagen porous matrices were suggested to 
be used as scaffolds in tissue engineering with improved resistance to enzymatic 
digestion and mechanical properties.  
The formation of water insoluble biocompatible hyaluronic acid polyion 
complexes, without the contribution of a crosslinking agent, was illustrated by the 
patented study of Nishida et al. (1993). In this study, polyion complexes were formed 
through ionic bonds between the carboxyl groups of hyaluronic acid and the amino 
groups of a high molecular weight natural compound and the mixture ration was 1:1. 
The resulting complex was insolubilized to water while retaining excellent water 
absorptivity. It was proposed that the polyion complex can be used a film, tube, etc. for 
an artificial organ such as an artificial heart, an artificial blood vessel and skin etc. 
owing to the excellent biocompatibility of both polyelectrolytes. Later, in 2003, Surini 
et al. attempted to develop a polymeric implant device for the sustained-release of a 
protein drug by utilizing the interaction between chitosan and hyaluronic acid. In this 
study pH and polymer mixing ratio dependence of polyion complexes composed of 
hyaluronic acid and chitosan were investigated. Chitosan, which is also a natural 
polysaccharide, was used as the high molecular weight cationic polyelectrolyte 
pronounced in the study of Nishida et al. This study represented the formation map of 
polyion complexes with respect to pH and weight ratio of the biopolymers. The results 
highlighted the formation of complexes within the pH range where two polyions were 
oppositely charged with a binding ratio of 1:1. The complexes formed were used to 
prepare pellets, which were employed to in vitro insulin release studies. The results 
suggested that polymer-mixing ratio is effective on the release. The release was 
controlled by the three-dimensional network structure of the complexes. In addition to 
this, Kim et al. (2003) reported the electrical sensitive bending behaviour of 
polyelectrolyte complexes composed of chitosan/hyaluronic acid. The bending angle 
measurements were performed in the non-contact DC electric field. Polyelectrolyte 
complexes have shown quick and significant bending that is reversible under the applied 
electric field. The swelling and bending characteristics of the films based on pH and 
medium ionic concentration was also investigated. The results of the study signified that 
such a PEC system can be useful for artificial organ components, sensors, switches and 
electric current mediated drug delivery systems.  
 
39
CHAPTER 3 
 
AIMS OF THE STUDY 
 
The main goal of this thesis was to investigate the complexes formed between 
silk fibroin (SF) and hyaluronic acid (HA). The main motivation is to be able to control 
the delivery of a charged model drug through films, prepared by silk fibroin-hyaluronic 
acid complexes, iontophoretically. 
The specific aims of the study can be summarized as follows: 
 To get insight into complex coacervation between silk fibroin and hyaluronic 
acid and characterize SF/HA complexes 
 To characterize the formation of the SF/HA complex films 
 To study the effect of temperature and pH on the swelling characteristics of 
SF/HA complex films. 
 To study the effect of iontophoresis on the permeation and release of a model 
drug through SF/HA complex films. 
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CHAPTER 4 
 
EXPERIMENTAL 
 
4.1. Materials 
 
Silk Fibroin (SF) was obtained in reeled form from Bursa Institute for Silkworm 
Research (Bursa/Turkey). Hyaluronic acid (HA) sodium salt (MW: 1,600,000 Da, form 
Streptococcus equi) was provided by Fluka-BioChemica (Buchs, Switzerland) in 
powder form. Di-sodium hydrogen phosphate, phosphate dihydrogen phosphate (acid 
and base components for phosphate buffer), ethanol (absolute GR for analysis) and 
sulfuric acid (98+%) were from Merck (Darmstadt, Germany). Calcium chloride-2-
hydrate and sodium chloride were supplied from Riedel-de Haën (Seelze, Germany), 
sodium carbonate (99.5+%) was from Aldrich-Chemie (Steinheim, Germany) and 
timolol maleate salt (MW=432.5) was from Sigma (St. Louis, MO, USA). Dialysis 
tubing (MW Cut-off: 12,000-14,000) was obtained from Sigma (St. Louis, MO, USA) 
and Medicell (London, UK). Sodium sulfide hydrate was provided by Fluka Chemie 
(Buchs, Switzerland). Deionized water was used during all experiments.  
 
4.2. Methods 
 
 The methods included were divided into four parts. The first part included the 
preparation and characterization of the SF and HA stock solutions. Second part 
explained the analysis employed for the characterization of the complex coacervation 
between SF and HA, and third part included the preparation and characterization of the 
SF-HA complex films by instrumental analysis. In the last part, the methods applied for 
permeability and diffusion studies were described. 
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4.2.1. Part I. Preparation and Properties of SF and HA Stock Solutions 
 
4.2.1.1. Preparation of Stock Solutions 
 
Silk fibroin solutions were prepared by subsequent processes of degumming and 
dissolution as described in Figure 4.1. During the degumming process, raw silk was 
kept in 50 times (v/w) of boiling aqueous 0.05% Na2CO3 for 30 minutes and this 
treatment was repeated three times. This was followed by washing several times with 
deionized water and the degummed silk was left drying at room temperature.  
To obtain aqueous SF solution, 1.2 g degummed silk was added to 20 times 
(v/w) of Ajisawa’s reagent (CaCl2/ethanol/water, 111/92/144 in weight) in a Schott 
bottle with a volume of 250 ml (Yamada et al. 2001). Higher amounts per batch of 
dissolution were avoided due to observed gelation during dialysis. The mixture was 
stirred at 78 °C to form a clear solution for 2 hours. The resulting SF solution was then 
dialyzed against deionized water for at least 3 days at sub-ambient temperature to 
remove the neutral salts using a cellulose tubing. Preparation of the cellulose dialysis 
tubings prior to usage is given in Appendix A. Dialysis was accomplished in 2 liter 
Erlenmeyer flasks. The water change was done for half-an-hour intervals for the first 2 
hours and then for 12-hour intervals for the rest of the 3 days. Eventually, the dialysis 
was ended as the dialysate tested negative for chloride ion by performing silver chloride 
precipitation test using AgNO3.  
It has been observed that undissolved fibers and particles may have a seeding 
effect during the concentrating step. Therefore, the dialyzed fibroin solution is filtered 
with a Filtrak 389 filter paper (Barenstein, Germany). The pure aqueous fibroin solution 
with a concentration of 1-2% (w/v) was obtained after filtration. The concentration of 
the SF solution was controlled using a rotary vacuum evaporator, Heidolph Laborota 
4001, run at 30°C and 30 rpm to avoid crystallization induced by temperature and shear 
stress. It was preferred that aqueous silk fibroin solution is prepared by Ajisawa’s 
method just prior to use since the waited samples has shown tendency to form a gel.  
HA was provided in powder form and it was soluble in water or any buffer 
solutions considered. However, HA particles were prone to coagulation during 
dissolution; therefore HA solution was stirred overnight to ensure complete 
solubilization.  
 
 
42
 
Figure 4.1. Step-wise preparation of aqueous silk fibroin solution from silk fibers. 
 
4.2.1.2. Molecular Weight Determination of SF 
 
The SF average molecular weight (MW) was determined by size exclusion 
chromatography (SEC). The system consisted of ZORBAX GF-250 column, HPLC 
(Agilent Tech. 1100) and a UV detector. The column was calibrated with two albumin 
standards: Egg Albumin (MW = 45,000) and Bovine Albumin (MW = 66,000) obtained 
from Sigma. 20 µl of sample dispersion (0.5 wt%) was injected into the column after 
filtration through 0.45 µm filters. Mobile phase was 200 mM sodium phosphate (pH 
7.0).  Flowrate through the column was kept at 2 ml/s. 
 
 
Pure aqueous 
fibroin solution  
Raw silk 
Degummed silk 
(sericin-free fibroin fibers) 
Dissolution in 
Ajisawa’s solution
Dialysis  
in cellulose tube 
Rotary
Evaporator
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4.2.1.3. Electrophoretic Mobility Measurements 
 
Measurements were performed with Zeta-Sizer (Malvern Ins.) apparatus. The 
biopolymer dispersions were injected using a plastic shringe into a quartz-measuring 
cell containing two electrodes. Three experiments (and three runs per experiment) were 
performed. 0.1 (w/v) % HA and SF dispersions were prepared with 10-3M KCl solution.  
 
4.2.2. Part II. Preparation & Characterization of SF-HA Complexation 
 
All experiments based on silk fibroin – hyaluronic acid complex coacervation 
was studied in salt free systems since it has been reported that salt has a screening effect 
on the ionic interaction between the two polymers constituting a binary polyelectrolyte 
system (de Kriuf et al. 2004, Weinbreck et al. 2003a). The analyses were performed at 
room temperature since variations in temperature does not influence the coacervation 
which also signifies that complexation does not include a strong contribution of 
hydrophobic interactions (Kaibara et al. 2000). 
 
4.2.2.1. Turbidimetric Analysis 
 
As a simple method to evaluate biopolymer complexation between SF and HA, 
turbidity of the mixed solution was measured at varying total biopolymer concentrations 
(0.1-2.5 wt%) and biopolymer ratios with respect to pH. The pH of the mixture was 
measured with WTW pH-meter (Inolab) equipped with a Sentix 41 pH electrode, which 
was calibrated with pH 7 and pH 4 buffers. Initially, the pH of the mixture was adjusted 
to pH 5.4 by 0.1 M NaOH. The turbidity of the solution was measured as a function of 
pH by titrating with 0.1 M NaCl with gentle magnetic stirring. Prior to each 
measurement, acid tirated mixture (30 ml) was stirred until the preset pH level was 
reached to a constant value. Then, the mixture was dispensed to the special glass bottles 
of the turbidimeter. The turbidity of the SF-HA mixtures was then monitored by using 
HACH 2100AN turbidimeter.  
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4.2.2.2. Conductometric Analysis 
 
Conductometric analysis were carried out to get additional information about 
complex formation between SF and HA through changes in conductivity of the system. 
All measurements were performed with WTW Cond 340i conductometer set with a 
probe of TetraCon 325 at room temperature (∼25 °C). In order to avoid changes in pH 
during titration both protein and polysaccharide solutions were adjusted to the same pH 
level (3.0). The pH level was selected with respect to the results of turbidimetric 
titration measurements. A volume 40 ml HA solution (0.5 wt%) was titrated by adding a 
solution of 1.0 ml SF solution (2.0 wt%) as the titrant. The system was continuously 
stirred, and after each addition the conductivity was measured and recorded as a 
constant value was reached. On the other hand, pH of the system was also checked 
frequently.  
 
4.2.2.3. Gravimetric Analysis 
 
The gravimetric yield studies were based on the study of Barbani et al. (1999). 
Six sample mixtures were prepared by adding 3 ml (0.3 wt%) HA to each and varying 
the SF volume added between 0.5 – 7 ml. The final volume in each tube was brought to 
10 ml by addition of deionized water at the selected pH. pH of the solutions were 
adjusted by 0.1 M HCl while being stirred in a 25 ml beaker.  Then the mixtures were 
dispensed into test tubes and centrifuged at 3000 rpm for 1 hr. Same procedure was 
applied for pure fibroin and HA solution. The supernatants were analysed by Shimadzu 
UV-1600 spectrophotometer with the absorbance measuring at 272 nm (specific 
wavelength for fibroin) and 229 nm (specific wavelength for hyaluronic acid) to search 
for the excess amount of each component. On the other hand, the phase-separated 
coacervates were washed twice with deionized water at the same pH of the experiment, 
dried and weighed. The amount of coacervate formation and separation was evaluated 
using the formula given below: 
Coacervation yield (wt%) = 
HAofweightSFofweight
eredcovrecomplexofweight
+   (4.1) 
 
and it was represented as a function of SF concentration.  
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4.2.2.4. Viscosimetric Analysis 
 
Intrinsic properties of biopolymer solutions were measured using a Brookfield 
DV-III rotational Rheometer interfaced to a personal computer and driven by a software 
package supplied by the manufacturers. The range of the rotational speed was 4 - 163 
rpm. Shear rate was started from 5 s-1 and increased up to 200 s-1 with an increment of 5 
s-1. The data was collected at 5 seconds intervals as an average of the three simultaneous 
measurements. The viscosity measurements were carried out at room temperature 
(∼25°C) on 20 ml samples. Pure silk fibroin samples were 0.016 g/ml and hyaluronic 
acid samples with a concentration of 5x10-4 g/ml with respect to its viscous nature.  The 
viscosity of the complexes were measured for a total biopolymer concentration of 0.5 
(w/v) % at a SF:HA weight ratio of 32:1 and 16:1. The measurements were executed at 
three different pH values (7, 3.14 and 2.3) and repeated twice. 
 
4.2.3. Part III. Preparation and Characterization of SF-HA Films 
 
4.2.3.1. Preparation of SF-HA Films 
 
Regenerated silk fibroin (RSF) solution adjusted to desired concentration and 
sodium hyaluronate dissolved in water are mixed at a preset ratio. RSF is slowly poured 
on the HA solution. The order of biopolymer mixing was reported to be effective on 
complex formation and structure of the complexes formed. It was suggested that as the 
whey protein was added to the exopolysaccharide B40, a turbid dispersion was 
obtained, as if to each polysaccharide chain some protein were adsorbed (Weinbreck et 
al. 2003b). For this reason, addition of HA on SF solution was preferred to simulate the 
referred system and the opposite technique was also tested. 
The pH of the solution was concurrently monitored and the pH was adjusted to 
pH value between the pKa of HA and IEP of SF. The mixture was stirred for 4 hours 
and casted on polyethylene Petri-dishes (Diameter = 5 cm) at room temperature. In case 
of drug loading, the films were mixed for 2 more hours after drug addition. The casted 
films were dried at 20 °C and at 80% RH for the first 2 hours, 65% RH for the following 
 
46
2 days in an environmental chamber (Angelantoni Industrie, Italy). The preparation 
conditions and type of the complexes were given in Table 4.1 below. 
 
Table 4.1. Detailed description of the preparation conditions of the complexes. 
Film 
Label pH R* Drying Condition Description 
F1 3.2 - 45°C, 65% RH Pure SF film 
F2 5.5 - 20°C, 65% RH Pure SF film 
F3 5.5 20 20°C, 65% RH SF-HA film 
F4 3.2 20 20°C, 65% RH SF-HA film 
F5 3.2 30 20°C, 65% RH SF-HA film 
F6 3.2 30 20°C, 65% RH SF-HA coacervate particles
F7 3.2 20 room conditions SF-HA film 
F8 3.2 - 20°C, 65% RH Pure HA film 
F9 3.2 20 20°C, 65% RH Drug loaded SF-HA film 
 R*: (SF:HA wt ratio) 
 
The dried films were stored in a desiccator at 10 °C until used to avoid 
contamination. The solubility of the films was controlled by immersing in deionized 
water and buffer solutions, whereas the thickness of the dried and swollen films was 
measured by an electronic digital micrometer.  
 
4.2.3.2. Swelling Measurements 
 
Swelling measurements were performed at 5 different pH values from 2.5 to 7.4 
at both 37°C and 50°C. After immersion in citric acid buffer at a desired temperature 
and pH, the film was taken from buffer solution, filter paper-dried by blotting to remove 
the absorbed water on the surface and then weighed immediately on an electronic 
balance. The film was repeatedly weighed and reimmersed in solution at predetermined 
pH and temperature until the hydrated weight reached a constant value. 
The swelling defined as, the weight of water uptake per unit weight of dried 
films (given by Eqn. 4.2) (Kim et al. 2005), was calculated by measuring the weight of 
swollen films until the weight changes within 1% of the previous measurement.  
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Swelling (%) = 100×−
d
ds
W
WW   (4.2) 
 
Where Wd is the weight of the dry film and Ws is the weight of the swollen film. 
Each swelling experiment was repeated three times and the average value was taken as 
the percentage of swelling value.  
 Cyclic pH-responsive swelling tests were performed at preset two pH levels, 2.5 
and 7.4, where considerable alterations in swelling can be observed. The films were 
exposed to solutions at pH 2.5 and 7.4 for 30 min and the cycles were repeated for 5 
times.  
 
4.2.3.3. Material Characterization 
 
Complexes precipitated in aqueous solutions (F6) and the homogeneous films 
casted from the complex mixtures (F4, F5), as well as the coacervate formation, were 
characterized by instrumental analysis techniques. 
Thermal analysis of SF-HA coacervates and complex films were determined by 
a differential scanning calorimeter (DSC) (Schimadzu DSC-50) in the 25 – 450°C 
temperature range at a scan rate of 10°C/min using stainless-steel pans under nitrogen.  
Scanning Electron Microscopy (SEM) (Philips XL 30S FEG) analyses were 
performed to show the morphological changes in the membranes. The films were coated 
with gold-palladium by Polaron SC 7610 Sputter Coater prior to imaging. The porosity 
and the roughness of the films were determined by Atomic Force Microscopy (Digital 
Instruments MMAFM-2/1700EXL). The contact mode was used and 10 and 50 µm 
scales were used for the area scanned.   
The changes in the crystalline state were monitored by X-ray diffractometer 
(XRD) (Philips X’pert Pro) with CuKα radiation for 2θ from 7 to 70°. 
Fourier Transform Infrared Spectroscopy (FTIR) analysis was carried out in the 
spectral region of 700-4000 cm-1 using an FTIR spectrophotometer (Digilab FTS 3000 
Mx) equipped with ATR diamond cell accessory.  
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4.2.4. Part IV. Permeability and Release Studies 
 
4.2.4.1. Choice of the Model Drug 
 
Timolol Maleate (TM) is a nonselective beta-adrenergic blocking agent that is 
used in the management of hypertension, angina pectoris, myocardial infarction and 
glaucoma. It undergoes extensive first-pass metabolism and its elimination half-life is 2-
2.6 h. TM (pKa=9.21) exists as predominantly charged ions (98.45%) at pH 7.4. 
Molecular structure of TM was given in Figure 4.2. It was demonstrated that 
transdermal delivery of TM would avoid first-pass metabolism after oral administration 
and would improve the bioavailability of the drug (Kanikkannan et al. 2001).  
 
 
 
Figure 4.2. Structure of timolol maleate salt 
(Source: WEB_6 2005). 
 
Timolol was chosen as a model drug because it is transdermally well tolerated in 
humans, it permeates through human skin (Kubota et al. 1991), and it has suitable 
chemical properties (weak base, pKa≈9.2, adequate lipophilicity) for transdermal 
administration (Sutinen et al. 1999).  
 
4.2.4.2. Drug Permeation Tests 
 
 The permeability of the model drug, timolol maleate, through SF-HA complex 
films was measured at pH 2.5 and 7.4 at 37°C by a modified diffusion-vessels method 
(Yoshizawa et al. 2004). The system used in this study was schematically represented in 
Figure 4.3. Initially, the bottle cap of a smaller vial (20 ml) was punched and the film 
was placed between the cap and the packing material. Then this smaller vial, which 
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constituted the donor, was filled with drug solution. The vial was firmly capped with the 
punched cap, tested for any leakage for 2 hours, and then placed into a larger vial (180 
ml) (receptor). The larger vial contains the buffer solution and shaken at 100 rpm to 
eliminate a boundary layer effect. Except the packing, no support material was used 
since the films were mechanically strong in wet state.  
 
 
Figure 4.3. Vial-in-vial permeation testing system. 
 
The initial donor concentration was 2.0 g/dm3 and the effective surface area for 
flux was 1.5 cm2. The pH of the donor and the receptor solutions were adjusted to the 
same pH level with high precision. The aliquots (0.2 ml) were taken with 1-hour 
interval and UV-spectroscopy (Shimadzu, UV-1601) was used to measure the 
concentration of the drug in the receptor solution at 294 nm wavelength. 
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4.2.4.3. Drug Permeation and Release Tests:  
Passive vs. Iontophoretic Delivery Applications 
  
A schematic drawing of the experimental set-up for the iontophoresis 
applications is given in Figure 4.4. The set-up primarily consisted of a diffusion cell, the 
Iomed iontophoretic drug delivery device used as the power supply and the UV visible 
spectrophotometer with the in situ flow cell installed. Phosphate buffer saline ([NaCl] = 
0.1 M) at the physiological pH 7.4 was used as the acceptor fluid. The flow of the buffer 
solution (approximately 2 ml/min) through the diffusion cell was provided by a 
peristaltic pump.  
 
 
 
Figure 4.4. Iontophoretic drug release set-up.  
 
 A custom-made diffusion cell, schematically shown in Figure 4.5, was used 
within the system. This cell includes two polytetrafluoroethylene (PTFE) parts joined 
end to end and an o-ring in between. The membrane is sealed with two gaskets and 
fixed in the middle as the parts are joined and externally squeezed. Silver/silver chloride 
disc electrodes (Diameter = 1 cm) were used during the experiments to prevent 
electrolysis of water. The silver electrode was placed in the anodal compartment and the 
silver chloride electrode in the cathodal compartment.  
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 The design of the cell enables the in situ analysis of amount of the drug 
delivered to the receptor solution. This was achieved by designing a small volume for 
the receptor chamber, which is 4.2 ml. The diameter of the opening between the 
compartments is 13 mm, which gives an active membrane are of 3.2 cm2. The design of 
the cell ensures an undisturbed laminar flow in the receiver side and mixing was not 
required.  
 
 
 
Figure 4.5. Custom-made diffusion cell for iontophoresis applications.  
 
The upper chamber, having a volume of 5 ml, was filled with PBS or drug 
dissolved in PBS for release studies or permeability studies, respectively, via injection. 
As the experiment started, the PBS solution was pumped through the receptor chamber 
and then passed through the flow-cell installed in the UV visible spectrophotometer, 
which was connected to a computer. The data was recorded and monitored by the use of 
software. The effluent leaving the flow-cell was collected in a beaker. 
 Maximum current density applied was 0.5 mA/cm2, which has been reported as 
the maximum acceptable density for the iontophoretic transdermal delivery producing 
minimal skin damage and irritation (Van der Geest et al. 1998).  
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CHAPTER 5 
 
RESULTS AND DISCUSSION 
 
5.1. Part I. Properties of the SF and HA Dispersions 
 
Silk fibroin (SF) aqueous solution was obtained by the dissolution of degummed 
silk fibers in high strength aqueous salt solution of CaCl2 at the amounts proposed by 
the Ajisawa’s method. Eventually, aqueous fibroin solution was obtained by dialysis 
process following dissolution. It has been known that treatment with high salt 
concentration of salt solutions results in smaller polypeptide chains. For this reason, 
molecular weight of the fibroin solution prior to regeneration was investigated. 
 Silk fibroin presented a polydisperse molecular weight distribution. Size 
exclusion chromatography analysis of the various SF solutions showed that the average 
molecular weight of the prepared SF solution was 90 kDa, with a maximum of 240 kDa 
and minimum of 16 kDa. In literature, the results of SDS-PAGE analysis of native 
fibroin from silk glands was given and clear protein bands having molecular masses of 
350 and 25 kDa were obtained by Yamada et al. (2001). The polydispersity in the 
results with the knowledge of the molecular mass of the native silk fibroin denoted that 
the native fibroin molecule degraded into a mixture of polypeptides of various sizes 
during the preparation of the fibroin solution.   
The pH of the prepared aqueous fibroin solutions (10 wt%) were in the range of 
6.2 - 6.7. In the study of Kim et al. (2004), it has been reported that fibroin solutions 
prepared with LiBr resulted in a pH range of 6.5-6.8, whereas the solutions prepared 
with Ajisawa’s method by the use of CaCl2, had the pH values within the range of 5.6-
5.9 due to formation of fibroin cluster by the Ca2+ ions. Relatively higher pH range 
obtained showed that Ca2+ ions could be excluded from the solution medium before the 
formation of ion bridging induced by this divalent ion.  
Prior to complexation experiments, electrophoretic mobilities (µe) of the two 
biopolymers were investigated in order to predict the most appropriate region for the 
formation of the electrostatic complexes (Figure 5.1). The µe of the hyaluronic acid 
(HA) was negative during all analysis and increased with increase of pH, i.e.  -3 e.m.u. 
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at pH 3.08 vs -4.5 e.m.u. at pH 5.01. The pKa value of hyaluronic acid was determined 
as 2.5, which was compatible with the pKa value of the carboxyl groups that was 2.5, 
but lower than the reported pKa value of HA, which was given as 2.9.  
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Figure 5.1. Electrophoretic mobility of 0.1 wt% biopolymer dispersions at 20°C. 
 
  µe of silk fibroin decreased by increasing the pH (5 e.m.u. at pH 2.97  to -0.1 
e.m.u. at pH 3.93). The variation of µe was dependent on the charge balance between 
the amino and carboxyl groups carried by fibroin. A zero value was obtained around pH 
3.9, which indicated the isoelectric point (IEP) of the prepared SF sample. In literature, 
it has been given within the range of 3.8 - 4.2. According to these measurements, strong 
electrostatic interactions between the two biopolymers should be effective in the         
2.5 - 3.9 pH window, where the µe of biopolymers are of opposite charge.  
 
5.2. Part II. SF-HA Complexation 
 
Studies on complex formation between SF and HA were based on the effect of 
pH. As the pH of the medium strongly affects the charge density of the biopolymers, it 
determines the strength of complexation. In this part of the thesis, the pH-window of 
complexation has been established using turbidimetric, gravimetric, conductometric and 
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viscosimetric analysis as well as macroscopic observations. On the other hand, the 
influence of total biopolymer concentration (Cp) and the ratio of the two biopolymers   
(R = SF:HA weight ratio) on complexation have been shown. 
 Electrophoretic mobility studies represented in the previous section showed that 
silk fibroin is in the protonated form, positively charged, below pH 3.9, wheras above 
the pH 2.5 hyaluronic acid is in the deprotonated form, and hence negatively charged. 
For this reason, complex coacervation was expected between these pH values. 
  
5.2.1. Turbidimetric Titration under Acidification 
 
Turbidity is proportional to both the molecular weight and the concentration of 
the particles in a system. Therefore, turbidimetric analysis presents a powerful 
technique in monitoring the formation of coacervate complexes. Turbidimetric titrations 
were performed to obtain qualitative information about the interaction of SF and HA. 
The mixtures of SF and HA showed good compatibility when mixed and a 
transparent solution was obtained with no precipitate formation above the pH of 5. 
Turbidimetric curves of the acid titrated SF-HA mixtures were shown in Figure 5.2 and 
Figure 5.3 in terms of NTU (Nephelometric Turbidity Unit) vs. pH. These figures 
revealed that complexation between SF and HA were in the favor of the proposed pH-
window.  
Figure 5.2 represented the titration curves of SF and HA mixtures for the Cp’s of 
0.5 wt% and 2.5 wt% at constant SF:HA weight ratio (R) of 32:1. At pH > IEPSF, both 
SF and HA are negatively charged and hence repulsive Coulombic forces prevented the 
complexation. This showed that biopolymers were soluble in the mixture and the system 
exhibited a blend of two biopolymers miscible in each other. In this region the turbidity 
was constant and low comparable to those of the pure biopolymer solutions. Further 
decrease of the pH led to the increase in turbidity. All curves illustrated that turbidity 
represented a gradual increase until a certain pH value as the pH of the mixture 
approached to the isoelectric point of fibroin (IEPSF = 3.9). The very first small 
variations in turbidimetric signals in a polyelectrolyte mixture were considered as the 
pHc (pH critical) as the formation of primary soluble intrapolymeric complexes by 
numerous researchers. This variation was seen within the pH range of 4.5 - 6. However, 
these small variations can be more clearly seen by light scattering (Weinbreck et al. 
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2003a), as it occurs on the molecular level. The possibility of such variations above IEP 
of the protein, on the wrong side of the IEP, was attributed to the existence of a local 
protein domain forming a charge patch with an effective charge opposite in sign to net 
protein charge (Grymonpré et al. 2001). Around pH 3.5 a strong increase in system 
turbidity was observed and this point was generally symbolized as pHφ, coacervate 
formation pH (Turgeon et al. 2003). This significant increase in turbidity indicated the 
aggregation of the intrapolymeric complexes giving rise to coacervation, but not the 
beginning of phase separation.  
These observations were in the favor of the formation of electrostatic complexes 
between the two biopolymers and can be confirmed by the sharp increase of the 
turbidity values of the dispersions as the protonated amino groups of the protein 
associated with the deprotonated carboxyl group of the polysaccharide.  
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Figure 5.2. Turbidity of pure SF (▲) and HA (●) solutions; and SF-HA system as a 
function of pH for Cp=0.5% (○) and Cp=2.5% (□) with SF:HA ratio of 
32:1.  
 
The curves overlapped differing only by their intensities by the existence of 
small pH shifts and they showed a peak around pH 3.0. This revealed that complex 
coacervation was independent of total biopolymer concentration as reported by 
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Weinbreck et al. (2004). As demonstrated in earlier studies, total biopolymer 
concentration only influenced the amount and probably the size of the complexes 
formed. On the other hand, during turbidimetric titration analysis it was recognized that 
there was no coacervate formation below Cp of 0.1 wt% (results not shown here), which 
simulated the co-soluble highly diluted case for this system.  
The curves were symmetrical and initial turbidity values reached through the pH 
of 2.5. It was also observed that the maximum turbidity levels reached with an abrupt 
elevation with small increases in the total biopolymer concentration.   
Acidic titration was carried out after monitoring of pH dependent maximum 
complex formation to check whether the aggregated complexes were reversible. 
Turbidity decreased as the dissociation of the carboxyl groups was suppressed, and 
hence the interactions between the biopolymers were weakened. The elevated turbidity 
values was seen due to complex coacervation pH values even lower than 2.9 (reported 
pKa of HA). This was attributed to lower pKa value (2.5) of the carboxylic groups 
(COO¯). Eventually, all coacervates dispersed spontaneously into soluble complexes. 
The final turbidity values were similar to that of the soluble complexes formed prior to 
coacervation. Therefore, one can conclude that the formation/dissociation of the 
aggregated complexes were reversible.  
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Figure 5.3. Turbidity of SF-HA system as a function of pH for SF:HA ratio of 32:1 (○) 
and 16:1 (∆) for Cp=0.5% . 
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On the other hand, as represented in Figure 5.3, as the SF:HA ratio was 
decreased, the maximum turbidity signifying the concentration and the molecular 
weight of the coacervates also decreased, which showed that SF was the limiting 
biopolymer for the coacervation. Moreover, the pH value where the maximum turbidity 
was obtained shifted to lower pH values, since fewer SF molecules were available per 
HA chain and a more acidic pH was necessary to provide more positive charges on SF. 
Therefore, charge compensation and stabilization and hence aggregation of the 
coacervates could be established by further protonation and resultant increase in the 
electrophoretic mobility of protein at lower pH levels for lower SF:HA ratio. 
Consequently, the pH at which the maximum complexation was obtained increased 
when the SF/HA ratio was increased.   
All the curves exhibited similar trends, with maximum turbidity around pH 3.0, 
which reported as the charge neutralization of the coacervates. Consequently, by 
turbidimetric titration, the complex coacervation between SF and HA was observed 
around the pH range of 2.5 - 3.5 as expected. The results showed that there occurred a 
pH-dependent two-step increase and symmetrical decrease of turbidity in the 
biopolymer mixture, pronounced as complex coacervation, and this was dominantly due 
to an electrostatic interaction between the SF and HA as given in Eqn. (5.1) below.  
 
               [HA-COO−] + [SF-NH3] ? [HA-COO−] [NH3+-SF]             (5.1) 
 
During the whole pH range turbidimetric analysis was performed, HA solution 
did not exhibit any change in turbidity. However, there was a slight increase in the 
turbidity of the SF solution around the isoelectric point. This was accepted as a typical 
behaviour of proteins since they aggregate around their isoelectric point as a result of 
charge neutralization.  
Complex coacervation could also be evidenced by naked-eye observations by the 
whitening of the biopolymer mixture as shown in Figure 5.4. At pH 7.12, the mixture 
was transparent, where there observed a change in the solution color as the pH was 
decreased and finally at pH 3.3 it was translucent with a white color. The centrifuged 
sample, which had a pH of 3.3, presented the complete phase-separation. Both phases 
were homogeneous. 
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Figure 5.4. Formation of soluble and insoluble complexes with respect to pH. 
 
Centrifugation was applied since settling of the coacervates was very slow. It 
was indicated by the study of Weinbreck et al. (2004)  that coacervate droplets settle 
down faster if they are fully charge-balanced than if some residual charges are present. 
The prepared SF:HA mixture at pH 3.0 was in excess of HA, therefore SF was in 
insufficient quantity and it could not totally compensate the negative charges of the HA. 
For this reason, a surface layer of HA stabilized the coacervates as the case reported for 
β-lactoglobulin and acacia-gum by Sanchez et al. (2002). The stabilization of the 
coacervates inhibited the interactions between coacervate droplets, and rearrangement 
of the coacervates was needed that resulted in longer time to settle down.  
 
5.2.2. Titration of HA by SF: Conductometric Monitoring 
 
To get more insight into complex coacervation of SF and HA, HA was titrated 
with SF at pH 3.0, where maximum coacervation was established in turbidimetric 
analysis. The response of the system to SF titration was analyzed in terms of 
conductivity (mS/cm) of the system vs. added amount of SF (ml).   
The conductometric curve, shown in Figure 5.5, showed a certain decrease and 
at a point change in the slope. Obviously the conductivity approached a constant value 
as the complexation proceeded. The decrease of the slope revealed that the complex 
formation began to form when the titration begins and the amount of formation 
increased during the titration procedure through the formation of intermolecular 
polyelectrolyte complexes through reversible transient ionic bridges. Instant turbidity 
formation after each addition of SF solution, but abrupt disappearance of the whitening 
pH = 3.3
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59
by stirring supported this approach. Thus, the initial sharper slope can be explained by 
the efficient pairing of active groups on SF and HA, which was partially and most 
probably regionally avoided and screened by existence of counter ions in the solution. 
On the other hand, coacervation may be also avoided because of the low energetic 
interest of the biopolymers in one phase due to high excess of HA. Consequently, the 
regular ionic crosslink between the monomeric units of the both polyion was interrupted 
because the monomer polyions cannot come to the mutual position as reported by Acar 
and Tulun (1996). 
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Figure 5.5. Conductometric titration at pH 3.0. 
 
By the SF addition proceeded, the critical size/charge ratio was reached, where 
coacervation started as the polyions rearranged themselves with a different coiling 
mechanism for an efficient pairing active groups due to stronger ionic interaction and 
higher affinity of the biopolymers. Thus, the slope of the curve changed, at which point 
the mixture also became translucent, as the effect of counter ions was overcome and so–
called microgel clusters formed trough cooperative coupling. This was also consistent 
with the knowledge of the screening effect of the ions on complex coacervation by 
addition of salt (de Kruif et al. 2004).  
The formed coacervate clusters were negatively overcharged due to residual 
charges on HA chains. Therefore, as more SF was added after the critical value, HA was 
buried within the ionic crosslinks. Thus, the conductivity reached to a certain value by 
further charge stabilization of the formed regular crosslinks.  
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On theoretical basis, SF carries 0.12 mmol amino groups and HA carries 2.5 
mmol carboxyl groups per gram. As shown in conductivity vs. added SF plot, around 45 
ml the plot showed a change in slope. This corresponded to a charge ratio (COO-/NH3+) 
of approximately 5, which can be assumed as the required critical charge ratio for the 
coacervation to start. It has been observed during several runs repeated that as the pH 
was decreased, the required amount of SF decreased up to five times and the 
coacervation occurred more abruptly. This was attributed to the increase in the fraction 
of the protonated amino groups, and the decrease in the fraction of the deprotonated 
carboxyl groups at lower pH values.  
 
5.2.3. Gravimetric Analysis 
 
 The yield and stoichiometry of the SF-HA coacervation was investigated by 
gravimetric analysis. Figure 5.6 represented the yield of complex formation with respect 
to SF amount in the complex mixture. As the initial SF:HA ratio was decreased, the 
coacervation yield decreased. The gravimetric analysis showed that maximum amount 
of precipitate obtained was close to 30%. This revealed that there existed an optimum 
SF:HA ratio ratio as well as an optimum pH for maximum amount of coacervate 
formation, where a large volume of highly concentrated polymers would be obtained. 
On the other hand, the UV analysis of the supernatants showed that there was high 
excess of both polymers that not incorporated in coacervate formation. This can be 
attributed to excess amount of HA employed to the system, smaller peptide chains of SF 
and the soluble complexes formed by the small peptide chains of SF and HA. It was 
reported that efficiency of coacervation was affected by the molecular weight of the 
protein and the polymers of smaller molecular weight formed smaller intrapolymer 
complexes of higher solubility (Wang et al. 1996). 
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Figure 5.6. Coacervation yield (%) vs. SF (g) in the complex mixture.  
 
The repeated gravimetric analysis showed that coacervate formation was also 
affected by the stirring time of the coacervate mixture. On the other hand, the trials for 
the contribution of higher amounts of SF in the biopolymer mixture did not permit the 
phase separation of the coacervates to achieve higher coacervation yields. It has been 
reported that when biopolymer concentration exceeds a critical value, biopolymer 
become limitedly co-soluble. The reason was shown as the large size and the rigidity of 
biopolymer molecules. Therefore, the entropy of mixing of biopolymers was several 
orders of magnitude smaller than that of the monomers. It was reported that biopolymer 
incompatibility may occur even the corresponding monomers were miscible in all 
proportions. Biopolymer incompatibility was observed between SF and HA biopolymer 
mixture when the concentration of SF exceeded 3 wt%. In literature, this value changed 
within the range of 2 – 12 wt% biopolymer concentration with respect to the charge 
density and the structure of the protein whether it is globular or fibrous (Tolstoguzov 
2003).  
Coacervate phase recovered from the complexation system was dried and 
weighed. The amount of coacervate formed with respect to ratio of available amino 
groups per carboxyl groups in the system was shown in Figure 5.7. By the addition of 
extra positive binding sites, the coacervate amount increased exponentially, since higher 
amounts of HA could be bound to protein chains. This exponential increase could be 
explained by the much higher molecular weight of HA. As the active binding sites were 
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increased, contribution of a larger molecule to the coacervate cluster was induced, 
resulting in a dramatic increase in the coacervate formation. 
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Figure 5.7. Coacervate (g) recovered from the complex mixture vs. ratio of the charges 
of the biopolymers at constant pH. 
 
The observed increase in coacervate amount after 1:1 pairing of the charged 
groups and the abrupt increase in coacervate amount showed that coacervation is a very 
flexible system. The system is capable of adapting its chain conformation and charge 
distribution by shifting the dissociation pH values of the charged groups to maintain the 
overall charge balance of the system. Similar case was observed in the system of whey 
protein/gum arabic coacervates (Weinbreck et al. 2004). It was reported that higher the 
initial protein to polysaccharide ratio, higher the ratio of the protein to polysaccharide in 
the coacervate phase regardless of the pH. It was unexpected since the biopolymers 
were mutually charge balanced at each pH with respect to protein polysaccharide ratio. 
Therefore, one can conclude that the complex formation betweeen SF and HA exhibited 
a non-stoichiometric behaviour, which is also the case for similar protein-
polysaccharide systems.  
Furthermore, the supernatant pH was lower than the initial adjusted pH level of 
the complex system at the end of the settling of the coacervates. The decrease in pH can 
be explained by Eqn. (5.2) similar to the chitosan-hyaluronic acid system (Lee et al. 
2003), if it was assumed that the pH of the supernatant was only induced by the 
presence of an excess acid extracted during the formation of the complexes. 
 
63
        [HA-COOH] + [SF-NH3+] ? [HA-COO−] [SF-NH3+] + [H+]      (5.2) 
 
According to Eqn. (5.2), the protons separated from carboxyl groups moved to 
the supernatant solution during the formation of the coacervates as the HA 
deprotonated. Since at the pH level adjusted, the dissociation of the carboxyl groups is 
constant, this showed that HA was incorporated into the system excessively. This also 
indicated the non-stochiometric behaviour of the system. On the other hand, during acid 
titration of the system (especially at the beginning of coacervation), before reaching a 
value, the pH of the homogeneous (not phase-separated) coacervate mixture showed an 
increasing trend. This increase can be explained by the Eqn. (5.3) below 
 
     [HA-COO−] + [SF-NH2] + [H+] ? [HA-COO−] [SF-NH3+]       (5.3) 
 
Most carboxyl groups were in the deprotonated state just below the isoelectric 
point of fibroin. However, the amino groups of fibroin is in -NH2 form. Thus, as the pH 
of the system was adjusted to a pH level, this level showed positive deviations as the 
amino groups were protonated. This may also lead to a conclusion that the response of 
the hyaluronic acid to titration, thus deprotonation was faster that the protons released 
by the deprotonation of carboxyl groups did not compensate this deviation.   
The induced conformational and structural change of the coacervate phase by 
the incorporation of the biopolymers in excess amounts also indicated that the 
biomaterials as various processed forms of the complex coacervates such as films, 
matrices can be prepared with differing diffusion and barrier properties.  
 
5.2.4. Viscosimetric Analysis 
 
 The viscosity measurements aimed to investigate the compatibility of the 
polymers in the mixture and the association between forming the interpolymer 
complexes in solution. If the viscosity, concentration, and weight fractions of the 
polymers are known, the following equation constituting the additivity rule of the 
biopolymers can be established (Lee et al. 2003): 
 
         )/()/()/( 222111 cwcwc m ηηη +=                   (5.4) 
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where subscripts (1) and (2) refer to SF and HA, respectively; c is the total biopolymer 
concentration; w1  and w2 are the weight ratios of the corresponding two biopolymers in 
the mixture; η1/c1 is the dynamic viscosity of SF at concentration of c1; and η2/c2 is the 
dynamic viscosity of HA at concentration of c2.  
 
Table 5.1. Calculated vs. measured viscosity. 
 
pH R 
Calculated 
Viscocitya (cP)
Measured 
Viscosityb (cP) 
2.3 32 0.83 1.66 
2.3 16 1.20 1.87 
3.2 32 1.72 1.69 
3.2 16 2.82 1.63 
7.5 32 2.17 2.30 
7.5 16 3.82 4.53 
a: Viscosity calculated by Eqn. (5.4). 
b: Viscosity measured at room temperature. 
 
 
 Measured and calculated viscosity values of SF-HA mixtures at varying weight 
ratio (r) and pH was given in Table 5.1. The results indicated that within the pH window 
for complex formation viscosity of the mixtures showed a negative deviation from the 
calculated viscosity values by Eqn. (5.4). This was attributed to formation of a compact 
interpolymer complex. On the other hand, the positive deviation occurred outside this 
window, which was attributed to good compatibility and gel-like association between 
biopolymers by Lee et al. (2003). It was reported that the viscosity decreased by a 
drastic reduction of the two polyelectrolytes through complexation, and formation of the 
compact complexes. In the gel-like complexes, expanded complexes, the viscosity may 
increase (Lee et al. 1997).  
The viscosity of the SF/HA mixture, regardless of the total biopolymer 
concentration and the ratio of the biopolymers in the mixture, decreases at the pH of 
complex formation. It was demonstrated by Bungenberg de Jung (1929) that the 
decrease in viscosity before and during the actual complexation was induced by the 
reduction of the amount of liquid occluded inside the complexes. The decrease in 
viscosity of the polyelectrolyte systems and low viscosity close to the point of 
complexation was reported to be consistent with intrapolymer condensation.  
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Figure 5.8. Viscosity vs. pH for Cp=1.5% and SF:HA=32 (?) ; Cp=0.5%  
and SF:HA=32 (▲); Cp=0.5% and SF:HA=16 (●). 
 
The effect of pH on the viscosity of the complexation mixture was shown in 
Figure. The viscosity measured at three pH levels (above, within and below the 
proposed pH window, 2.5 - 3.9, for complexation) were calculated as the average of the 
viscosity values recorded between the shear stress range of 40 - 200 cm-1. Larger 
variations below 40 cm-1, as seen in Figure 5.8, were excluded during calculations.  
The viscosity of the mixture decreased due to coacervate formation between the 
oppositely charged SF and HA around pH 3.0. Complex formation led to the shrinkage 
of the intrapolymer complex chains that decreased the viscosity of the system with more 
compact complex formation. The system turned into a colloidal dispersion from a blend 
of two biopolymers, which no more contributed their intrinsic viscosimetric properties 
into the system. Moreover, the viscosity of a dilute polymer mixture was expressed to 
be directly related to the size of the particles (Weinbreck et al. 2003b). Then one can 
conclude that the strongest and larger coacervates at higher amounts were formed at the 
minimum viscosity in relation with turbidimetric analysis.  
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Figure 5.9. Viscosity vs. shear stress plots of SF-HA complex mixtures at pH=3.0.  
The curves represent Cp=1.5% and SF:HA=32 (?) ;Cp=0.5% and 
SF:HA=32 (▲); Cp=0.5% and SF:HA=16 (●). 
 
Rather lower viscosity of the Cp=1.5% and SF:HA=32 case may be attributed to 
more compact and higher yielded complex formation and the viscosity increase due to 
increase in pH was less pronounced. In case of Cp=0.5% and SF:HA=16, the higher 
values for viscosity was obtained due to higher excess of HA. This was attributed to 
much higher viscosity of HA as compared to SF solutions and also by selective binding 
of HA to the poorly flexible chains of SF to form a precipitate of the complex with the 
increased amount of HA. 
The complexation mixture systems showed a limited shear thinning behaviour 
below the shear stress of 10 cm-1 as shown in Figure 5.9. In combination with the 
previous findings, sharper curves indicated stronger electrostatic interaction between 
biopolymers. Moreover, the phase separated coacervate phase was highly viscous while 
leaving very dilute solution above. In literature, this was confirmed and the coacervate 
phase was expressed as viscous particle dispersion rather than a concentrated 
viscoelastic polymer solution (de Kruif et al. 2004).  
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5.3. Formation and Characterization of SF-HA Complex Films 
 
The complex mixtures, prepared at the proposed pH window (pH 2.5 - 3.5), 
casted and dried under controlled temperature and relative humidity resulted in 
homogeneous transparent films. The preliminary evaluation of the films was their 
solubility in water. The films immersed in both water and various buffer solutions were 
insoluble, whereas pure SF and HA films prepared exhibited fast dissolution in aqueous 
media. At each mixing ratio or mixing order, within the proposed pH range, insoluble 
complex films with differing yields were obtained regardless of 1:1 pairing of the 
charged groups or the weight ratios. Tsuchida et al. (1972) and Kabanov et al. (1980), 
respectively suggested that when one of the biopolymers was in high excess, or when 
the host polymer was dropped upon the guest polymer, coacervation did not occur, and 
this suggestion was opposed by Dragan et al. (1996). Formation of insoluble complexes 
even at high excess of one of the biopolymers was shown as a proof for a greater 
stability of the polyelectrolyte complexes obtained in these conditions and an argument 
for a tight structure that could be achieved. A similar result was obtained for the 
complex formation between chitosan and carboxymethylcellulose (Argüelles-Monal et 
al. 1990). The complex was insoluble irrespective of the mixing way and of the excess 
of the complementary polymers. However, the situation could differ for other protein-
polysaccharide systems with respect to charge density and molecular conformation of 
the biopolymers.  
The complex films underwent a color change in aqueous media; they turned to 
milky white as shown in Figure 5.10. Such a color change was not observed for the pure 
SF and HA films prepared and dried under same conditions. The-color changing 
phenomenon in complex films was related to aggregative state of two biopolymers by 
Wang et al. 1997, that is analogous to the color change of the biopolymer mixture 
during the aggregation of the intrapolymer complexes with respect to induced pH 
changes. When the pH reached a critical value at a specific biopolymer ratio and total 
biopolymer concentration, deprotonated carboxylic acid groups of HA associated with 
the protonated amino groups of SF, which led to the complexation of the SF and HA 
chains. The orientation probably caused the refraction change of the light, so the casting 
solution turned milky-white (Wang et al. 1997). As the films were casted and left to 
drying, the milky-white gradually disappeared and dry transparent yellowish films were 
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obtained. Upon exposition to aqueous environment, they regained the milky-white 
appearance due to the associated complexes in the film. 
 
 
 
Figure 5.10. Appearence of dry (a) and wet (b) insoluble SF-HA complex film. 
 
 Mechanical properties of the materials are of primary importance for 
determining the performance in case of varying stress conditions. The pure SF film 
displayed the typical behavior of brittle materials, as reported. On the other hand, SF-
HA complexes was effective in inducing only a slight improvement on the mechanical 
properties of SF films. As HA content increased, more flexible films at dry state were 
obtained. The films were much more flexible before washed and excess of HA was 
removed. During the parallel studies carried out, SF was crosslinked with EDC (1-ethyl-
(3-3-dimethylaminopropyl)carbodiimide hydrochloride), and SF-HA complex was 
enhanced by EDC. These studies also showed that as the amount of HA in the insoluble 
system was increased by the inducing effect of EDC, more flexible films were obtained. 
It was also reported that EDC also increased the flexibility of the crosslinked films 
(Bayraktar et al. 2005). Incorporation of EDC or plasticizer, such as glycerol can be 
applied to the system to enhance the flexibility on dry state, however, this thesis mainly 
focuses on pure SF-HA complexes. In wet state, SF-HA films were strong and flexible, 
applicable to further analysis.  
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5.3.1. Morphological Examination of the SF-HA Complex Films  
 
 Milky suspension of fine coacervates formed by the complexation of SF and HA 
casted and dried at 20°C and 65% RH. The resultant film was examined by scanning 
electron microscopy (SEM) and Atomic Force Microscopy (AFM). Insoluble SF-HA 
complex films (F4 and F5) had smooth surfaces with finely distributed roundish 
particles as shown in Figure 5.11. In other words, the films displayed so-called sea-
island morphology, which was also met in the SEM photographs of chitosan-alginate 
polyelectrolyte complexes (Freddi et al. 1999). 
 
 
Figure 5.11. SEM photographs of the SF-HA complex film magnified at 2000x (a) and 
15000x (b). 
 
Figure 5.12 (a), (b) and (c) represented the cross-sectional view of the SF/HA 
complex film (F4). The upper side of the film shown in Figure 5.12 (b) was porous 
exhibiting a network-like morphology whereas the lower side of the film had a dense 
characteristic, resulting in an asymmetric cross-section structure. The porous and dense 
sections were magnified (2 µm) in Figure 5.12 (b) and (c), respectively. This may show 
up due to settling of the coacervate particles with higher molecular weight on the lower 
side of the film while leaving the upper side of the film poor in coacervates that led to a 
loose network structure. Asymmetric cross-sectional morphology was only met for the 
case when SF:HA weight ratio was 20, which corresponded to 1:1 pairing of the charges 
in the complex. When this ratio was exceeded, films resulted in denser membranes with 
a symmetric cross-sectional view. This was attributed to faster settling of the 
a b 
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coacervates at higher mixing ratios. Above this ratio, more compact and strongly 
associated complexes may form, resulting in a denser structure. Dense layer particle size 
was around 55 nm and this layer had a colloidal microstructure. The thickness of the 
film shown in Figure 5.12 was 87 µm.  
 
 
 
Figure 5.12. Cross section images of SF/HA complex film with magnification 100x (a), 
porous (b) and dense (c) regions of insoluble SF/HA film (15000x). 
b 
a 
c 
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Figure 5.13. AFM images of SF-HA PEC film with height view (a), view of roughness 
analysis (b), deflection view (c) and 3D height view (d). 
 
SF-HA complex film (F5) was immersed in water for 1 day and the water was 
refreshed periodically to remove the excess amounts of biopolymers and dried again 
under controlled conditions. This resulted in porous film with a low roughness. Figure 
5.13 (a) showed the 2D height image and (d) 3D height image, whereas (b) exhibited 
the deflection image and (c) showed image transition for the roughness analysis of the 
air-surface of the film shown in Figure 5.13 (b). The formation of a porous structure and 
the resulting network seen was attributed to the removed HA from the complex. 
Unreacted excess HA had probably stabilized the complex coacervates at the upper side 
of the film as a filler. When the film was immersed in water, loosely resided HA 
dissolved in water creating channels (functioning as an excipient) in the biopolymer 
matrix. High amount of HA in the immersion solution also supported this suggestion. 
The average pore size of the films was 215 nm and the porosity was homogeneous 
c 
a b 
d 
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throughout the film with a narrow pore-size distribution. Mean roughness of the 50x50 
µm2 scanned area was 4.716 nm and for the 10x10 µm2 scanned area it was 3.697 nm, 
which were comparable. Drying caused height elevations (lighter colored areas) as seen 
in AFM images of all films, however apart from these elevations, the films had a 
smooth texture.  
 
 
 
Figure 5.14. SEM photograph of SF-HA complex films dried under  
controlled conditions (a) and at room temperature (b). 
 
Figure 5.14 represented the insoluble SF-HA complex film (F5) dried at 20°C 
and 65% RH (a) and the complex film (F7) dried at room temperature (b). F5 was 
insoluble and F7 was partially-soluble in water. Although same SF:HA weight ratio was 
employed to both films, F5 resulted in a dense homogeneous texture, whereas F7 
exhibited a rather loose and heterogeneous structure. This effect was also clearly 
observed on AFM images of the complex films dried at room temperature as shown in 
Figure 5.15 below. The formation of and the size of the complex coacervates was 
uneven, whereas the variation of the environmental conditions and relatively faster 
drying kinetics resulted in both macroscopic and microscopic cracks on the surface of 
the films. In this figure, both height (a, c) and deflection (b, d) images of the contact 
mode AFM were obtained to show these cracks on the scanned areas of 50x50 µm2 (a, 
b) and 10x10 µm2 (c, d). 
 
a b 
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Figure 5.15. AFM images showing the formation of cracks on the complex film dried at 
room temperature given as height image for 50x50 µm2 (a) and for 10x10 
µm2 (c); deflection image for 50x50 µm2 (c) and for 10x10 µm2 (d). 
 
On the other hand, no crack formation was observed on the film dried at 20°C 
and 65% RH (F4) (Figure 5.15 (a)). This was attributed to the gradual evaporation of 
water, permitting films to dry at a proper rate, which led to the formation of 
homogeneously sized and distributed complex coacervates resulting in continuous films. 
It was observed that drying conditions had a strong effect on the film formation and the 
resultant film properties. 
The SF control sample (F1) with silk-II conformation were compact and flat 
with a height of 0.582 nm, whereas the formation of complexes resulted in an average 
height of 39.55 nm on the surface of the SF-HA complex film (Figure 5.16 (a)). Pure SF 
sample exhibited densely packed small-sized grains (Figure 5.16 (b)). It was reported 
that β-sheet SF films may exhibit several types of morphologies such as small particles, 
a 
c d 
b 
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grains or nanofibrils (Putthanarat et al. 2002). The complex coacervates were seen as 
roundish grains which also confirmed that they were liquid droplets. The lighter areas 
showed high degree of aggregation of the coacervate droplets.  
 
 
 
Figure 5.16. AFM images of SF-HA complex film (a) and SF control sample with silk II 
conformation (b) dried under controlled controlled conditions. 
 
5.3.2. Thermal Analysis 
 
Differential scanning calorimeter (DSC) is one of the techniques that has been 
applied to study the molecular conformation of silk-based materials and hence their 
physical and structural characteristics. Figure 5.17 below represented the DSC curves of 
the films prepared at different conditions. 
The secondary structure of B.mori silk fibroin (SF) consists of the major 
conformation including random coils (silk I) and β-sheet (silk II). The following 
evaluation of the molecular conformation of SF did not differentiate between random 
coils and silk I structures. It was claimed that distinction between the silk I and random 
coil was impossible even from IR spectra (Asakura et al. 1985). For this reason, both 
conformations were shown as silk I.  
(a) (b)
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Figure 5.17. DSC curves of the films. Pure SF film-II (F1), pure SF film-I (F2), SF-HA 
blend (SF:HA=20) (F3), SF-HA complex film (SF:HA=20) (F4), SF-HA 
complex film SF:HA=30) (F5), phase-separated coacervate network (F6), 
coacervate film (F7), pure HA film (F8). 
 
The pure SF films, F1 and F2, were both prepared at pH 5.5, but dried at 45°C 
and 20°C, respectively. Due to heat treatment, F1 was water insoluble and exhibited a 
strong endothermic peak at 305°C, which was attributed to thermal degradation of SF 
film with silk II conformation. On the contrary, F2 film, which was water soluble, 
showed an exothermic peak around 225°C due to crystallization of the amorphous 
fibroin from random coil (silk I) to β crystals (silk II). The peak of thermal 
decomposition of F2 shifted to a lower temperature (285°C as shown by the dashed line-
F1 
F3 
F4 
F5 
F8 
F2 
F7 
F6 
a b 
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a) with less intensity, by the lower degree of molecular orientation when compared to 
DSC trace of the F1 with β-sheet (silk II) conformation. The peak positions were 
consistent with reported DSC traces of the silk-I and silk-II type fibroin (Xu et al. 2005, 
Um et al. 2001 and Gotoh et al. 1997). 
F3 represented the DSC trace of the SF-HA physical mixture prepared at pH 5.5 
with a SF:HA weight ratio of 20, which corresponded to 1:1 pairing of the charged 
groups on the biopolymers. During the preparation of this mixture, no turbidity was 
seen as naked-eye observation. F3 exhibited a very similar curve to that of F2 with silk I 
structure. An exotherm was seen at 225°C with a lower intensity and a narrower but 
higher intensity endotherm at 285°C. The appearance of the endotherm also showed that 
SF/HA blending did not introduce crystallization. No effect of HA was observed in this 
curve or either in other curves including HA, of which DSC trace was shown with F8. 
This was attributed to partition of HA in the mixtures in very small weight amounts. 
The only difference between the traces of the physical mixture of SF-HA and pure SF 
film with silk I structure was the appearance of a shoulder around 290°C (shown by 
dashed line-b). This was assigned to the formation of soluble interpolymer complexes 
above the isoelectric point of SF due to local positive charge patches. This was 
consistent with the obtained pH-window for the formation of soluble complexes in the 
turbidimetric analysis. On the other hand, preparation of SF-HA complex film at pH 3.2 
at the same weight ratio introduced the formation of silk II structure to F4. As soon as 
two materials were mixed, turbidity (white-milky appearence) was observed during the 
preparation of the complex mixture at the specified pH. The resultant SF-HA complex 
film exhibited silk II conformation, and thermal degradation endotherm did not shift to a 
higher temperature as seen in case of F1 with a positive shift of 20°C. On the other 
hand, the shoulder seen on F3  around 290°C was sharper in case of F4 was attributed to 
transition of soluble intermolecular complexes to insoluble intrapolymeric complexes, 
which resulted in insoluble SF-HA complex films. This shoulder turned into an 
endotherm at the DSC curve F5, which was also prepared at pH 3.2 but at higher SF:HA 
ratio of 30. This increase beyond 1:1 stoichiometry was consistent with previous results 
showing the rearrangement of the charge distribution of the coacervate complexes 
leading to higher coacervation yields. Therefore, as the SF:HA ratio increases, 
complexes with higher thermal stability was obtained due to more compact 
complexation with stronger ionic interactions.  
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F6 exhibited the DSC trace of the coacervate phase centrifuged, filtered and 
dried under controlled conditions. Prior to centrifugation, complex mixture was 
prepared at pH 3.2 with a SF:HA ratio of 30. This procedure resulted in particles 
resembling a network like structure. DSC curve of the coacervate phase showed a 
broader endotherm at 290°C, which supported the appearence of a new peak at this 
temperature attributed to SF-HA complexation. The complex mixture prepared under 
same conditions waited for a gravity-induced phase separation, which was established in 
2 hours without centrifugation and left drying at room conditions. DSC curve of the 
resultant coacervate film, which was partially-soluble, was shown with F7. The 
endotherm showing the thermal degradation of this film was very similar to that of 
soluble fibroin film with silk I structure (F2). However, the crystallization exotherm at 
225°C was not seen, and the endotherm showing the coacervate formation just appeared 
as a plateau. Another point was that macroscopic and microscopic cracks were observed 
on this film as given by the AFM images of this film. Formation of partially-soluble 
films with crack formation under specified conditions signified the effect of drying 
conditions. Partial insolubility of the film (F7) was attributed to silk I to silk II 
transition. 
The exothermic peak at 225°C given as a marker of silk I conformation 
disappeared in all films prepared at pH 3.2. Moreover, the thermal decomposition did 
not shift to a higher temperature, which shows higher thermal stability gained by silk II 
conformation, for these cases. This was attributed to pH-induced conformational 
transition of SF, which probably occured at a lower yield when compared with the 
intensity and decomposition temperature shifts between the DSC traces of F1 and F2. 
These observations revealed that SF/HA complex films did not induce a transition to β-
sheet conformation, and complexation increased the thermal stability by 10°C which 
may be concluded as the result of the specific interactions between SF and HA, whereas 
SF in the complex films underwent a transition to β-sheet by some degree.  
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5.3.3. X-Ray Diffraction Analysis 
 
The following X-ray diffraction (XRD) analyses were performed to get more 
insight into characterization of the SF-HA complex films. Figure 5.18 represented the 
XRD patterns of F1 (SF film with silk-II conformation), F2 (SF film with silk-I 
conformation), F4 (SF-HA complex film, r = 20), F5 (SF-HA complex film, r = 30) and 
F8 (HA film) as previously exhibited in DSC analysis. In the figure the DSC patterns of 
the films were placed in the order of increasing crystallinity.  
SF film with silk-I conformation (F2) showed a weak and wide pattern around 
2θ=20° with a spacing of 4.8 Å due to noncrystalline form as the typical characteristic 
diffraction pattern of amorphous silk fibroin (Saitoh et al. 2004). HA-film also showed 
up a very broad pattern around 2θ=35°. On the other hand, F1 showed a typical 
diffractogram of β-sheet crystalline structure, which had three diffraction peaks: a major 
peak at 17.4° and two minor peaks at 14.3 and 26.3°.   
The diffractograms of F4 and F5 showed that crystalline and amorphous phases 
coexisted  SF-HA complex films. F4 (r=20) showed lower crystalline peaks at 14.3, 
16.9 and 25.5° and weak and broad peak around 20° representing noncrystalline 
structure, whereas F5 (r=30) exhibited a new broad peak at 7.5°, three crystalline peaks 
at 14.4, 17 and 25.4° and a stronger and narrower peak at 20°. The peaks representing 
the crystalline phases had lower intensity with small shifts when compared to that of F1 
and the intensity diminishes as SF:HA weight ratio increased. Small shifts and untypical 
peaks may be caused by the shear forces being effective on casting and drying, giving 
rise to β-sheet characteristics. On the other hand, it was reported that the appearance of 
unknown peaks or spacings may be due to other types of conformations such as helical 
and β-turns or distorsions by the presence of conformers and/segments in which torsion 
angles deviate from those of silk-I or silk-II (Ayutsede et al. 2005). 
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Figure 5.18. X-ray diffraction patterns of SF film-II (F1), SF film-I (F2), SF-HA 
complex film (SF:HA=20) (F4), SF-HA complex film (SF:HA=30) 
(F5), HA film (F8). 
 
 
These findings denoted that complexation between SF and HA through ionic 
interactions reduced the crystallinity, which was induced by the lower pH values that 
favored the β-sheet conformation for SF. Similar behavior was seen for the chitosan-
gelatin polyelectrolyte complex (Yin et al. 1999). It was reported that the crystalline 
peaks appeared on the XRD profiles of the complex became weaker with increasing the 
gelatin content. The weakening of the crystalline peaks induced by increasing the 
protein content of the complex was attributed to strong interactions between gelatin and 
chitosan that led their good compatibility.  
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5.3.4. FT-IR Analysis 
 
Another instrumental technique, infrared spectroscopy (IR), was employed to 
determine the molecular conformation and orientation of SF-HA complex films. IR 
spectrum in the 1800-800 cm-1 range of control can be a fingerprint of prepared films 
since it contains various absorption bands related to different chemical and structural 
features of the prepared films. ATR-IR spectra of the SF-HA complex films, Figure 
5.19, showed small but still significant changes with respect to the SF control film, 
which was prepared at pH 3.2 to check the conformation transition observed in DSC 
analysis. SF-HA complex film was also prepared at 3.2, with a SF:HA ratio of 20, 
simulating the film shown as F4 in the previous analysis. The resultant pure SF film 
showed slow and partial dissolution in water compared to that SF film prepared at pH 
5.5.  
Amide I-IV bands are conformationally sensitive bands for polypeptides and 
proteins. Their intensity and position of these bands give information about the 
molecular conformation of the materials examined in IR spectrum. In amide I and amide 
II regions of the IR spectra of the films, instead of a single characteristic peak, bands 
were observed. In literature, amide I (-CO- and –CN- stretching) appeared to be in the 
region of 1655-1660 cm-1, amide II (-NH- bending) in the region of 1531-1542 cm-1 and 
amide III (-CN- stretching) at 1230 cm-1 were attributed to silk I conformation. On the 
other hand, the appearance of amide I in the region of 1620-1630 cm-1, amide II in the 
region of 1515-1530 cm-1 and amide III at 1240 cm-1 characterized the β-sheet 
conformation (Ayutsede et al. 2005, Freddi et al. 1999, Wang et al. 1997). The 
appearance of strong and broad peak of SF-HA complex film (c) at 1240 cm-1 
represented that the dominant conformation was silk I, when compared to the β-sheet 
dominant conformation of  SF control film (b) which showed 1231 cm-1 absorption 
band of the silk II conformation. On the contrary, SF-HA complex film, as well as the 
SF control film, represented absorption bands of 1637 cm-1 and 1508 cm-1 with 
accompanying peaks of 1654 cm-1 and 1540 cm-1. In addition, the appearance of 950 
cm-1 (-NH- stretching) absorption band on IR spectra of the complex film favored the 
existence β-sheet crystals. Consequently, IR spectra of the films showed that  SF-HA 
complex film, as well as the SF control film, comprised mixtures of silk I (α) and  silk II 
(β) type conformations and complexation did not introduce a positive effect on 
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crystallization; on the contrary, decreased the crystallinity which may enhance during 
drying. The pH-induced crystalline structure of SF was disturbed by formation 
associative compact structures and/or the crystalline phases may be buried into the 
complexes with respect to higher degree of hydrophobicity due to charge stabilization of 
the complexes and the β-sheet conformation. 
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Figure 5.19. ATR-IR spectra of the casted films; HA (a), SF (b); SF-HA complex film 
(c) and drug loaded SF-HA complex film (d). 
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In addition to all, even though new conspicuous peak did not appear, 
considerable increase in amide I, amide II, amide III bands and at 1410 cm-1 
corresponding to valency vibration of carboxylate ion and formation of a shoulder at 
1095 cm-1 corresponding to –C=O- stretching for the SF-HA film evidenced the 
complex formation between the amino groups of SF and carboxyl groups of HA.  
SF-HA complex film (F9), shown in Figure 5.19 (d), was loaded with the model 
drug, timolol maleate, and the characteristic IR spectra of the drug loaded film (d) 
exhibited the highest increase in intensity, which showed that drug molecules that were 
positively charged at the mixing pH probably formed linkages with the excess of the 
deprotonated carboxylic acid groups of HA. 
 
5.3.5. Swelling Tests 
 
The investigations on swelling ability of SF-HA films were carried out in the 
media of pH 2.5 - 7.4. The weight of the films increased rapidly and equilibrated within 
3 hours. The swollen membranes had the milky-white appearance during all swelling 
experiments. Figure 5.20 and Figure 5.21 showed the pH-dependent swelling kinetics 
for the SF-HA complex film (F4) at 37° and 50°, respectively. The films swelled more 
in alkaline condition and shrank in acidic condition regardless of the temperature of the 
salt-free phosphate buffer solutions. The relatively higher swelling in alkaline condition 
occured since the carboxyl groups on SF and the unreacted pendent groups on HA 
probably dissociated into carboxyl anion in alkali condition, which caused the ionic 
repulsion between anionic groups in the network resulted in the conformational 
stretching and the films swelled. On the other hand, the films shrank in acidic condition 
with respect to the coiled conformation owing to the ionic affinity.  
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Figure 5.20. pH-dependent swelling kinetics of the SF-HA complex film at 37°C. 
pH 2.5 (◊); 3.2 (□); 6.5 (○); 5.5(∆); 7.4 (•). 
 
The plots showed that the reason of swelling was mostly due to ionic repulsion 
of the pendent groups on SF since the swelling ratios above and below the IEP of the 
protein was similar and dissociation of carboxyl groups on HA would be completed up 
to these pH levels since it had a very low pKa value. In the region of 2.5 - 4, the 
carboxyl groups on SF are in the form of –COOH with the excess H+ ions present in the 
solution. As the pH increased, H+ ion from carboxyl group combined with OH- in alkali 
and the carboxyl groups dissociated into carboxyl anion.  
The pH value and the degree of dissociation calculated according to Eqn. (5.5) 
are shown in Table 5.2. pKa of HA was taken as 2.5 with respect to electrophoretic 
mobility measurements (Sutani et al. 2002). 
 
                  
110
1
)( += − pHpKaα         (5.5) 
 
 Degree of dissociation of the carboxyl groups on HA does not show any changes 
above the pH of 4 - 4.5, which confirmed that dissociation of carboxyl groups on HA 
mostly occurred within the pH window of 2.5 - 4.5. Thus, the alterations in swelling at 
alkaline pH were due to dissociation of the carboxyl groups of SF creating higher ionic 
repulsion with the existed negatively charged groups. 
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Table 5.2. Degree of dissociation for HA with respect to pH. 
 
pH α 
2.5 0.50 
3.2 0.83 
4.5 0.99 
5.5 1.00 
6.5 1.00 
7.4 1.00 
 
 In general, for the polyampholyte gels, there occurs a u-shaped swelling profile 
having a minimum around the IEP of the polyampholyte showing the interaction of the  
anionic and cationic units. Shrinking at neutral pH was described by the presence of 
excess amino groups. In our case, there observed only an increase in swelling with the 
increase of pH approving that the cationic units were already consumed through 
complexation with the dissociated units of the HA. Therefore, in all pH levels the 
complex membrane was negatively charged. On the other hand, higher charge density of 
HA caused swelling of the membranes even at highly acidic conditions. Minimum 
equilibrium swelling percentage was recorded as 68% at pH 2.5 and 37°C. 
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Figure 5.21. pH-dependent swelling kinetics of the SF-HA complex film at 50°C.  
pH 2.5 (◊); 3.2 (□); 6.5 (○); 5.5(∆); 7.4 (•). 
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Equilibrium swelling of the complex films was found to be independent of 
temperature as shown in Figure 5.22 below for all pH levels studied. This indicated that 
complex coacervates were surrounded and stabilized by the excess of HA through high 
yield of complexation. As a result, the water molecules was highly ordered around these 
groups at the temperatures examined. Temperature dependent swelling was reported for 
membranes mostly having hydrophobic moieties (Yoshizawa et al. 2004). 
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Figure 5.22. Equilibrium swelling percentages of the SF-HA complex films  
with respect to pH at 50°C (•) and 37°C (○). 
 
Table 5.3 represented equilibrium swelling (%) of the various types of SF-based 
films at 37°C based on the pH and ionic strength of the swelling environment. 
Minimum swelling was obtained for the pure SF films with silk-II conformation due to 
its highly rigid structure and no change in swelling was observed with respect to 
changes in ionic strength. Maxiumum swelling was obtained at 0.1 M NaCl 
concentration and pH 7.4 which was attributed to increase in ionic osmotic pressure 
generated from mobile counterions in the network. Further increase of the ionic strength 
of the medium up to 1.0 M NaCl decreased the swelling levels, which denoted the effect 
of high concentration of counterions may hinder the ionic interactions between the 
carboxyl groups lowering the elastic-retractive force exerted on the network due to ionic 
repulsion.  
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Furthermore, loaded SF-HA complex film exhibited lower degree of swelling, 
which was attributed to formation of stronger complexes during preparation of the films 
and this was consistent with IR analysis of F9 film. 
 
Table 5.3. Equilibrium swelling of various SF films with respect to pH  
and ionic strength. 
 
Film Label pH NaCl Conc. [M] Equilibrium Swelling Ratio (%)
SF-HA Film (F4) 10.0 - 86 
SF-HA Film  7.4 - 85 
SF-HA Film  6.5 - 84 
SF-HA Film 5.5 - 81 
SF-HA Film 3.2 - 70 
SF-HA Film 2.4 - 67 
SF-HA Film 7.4 0.1 95 
SF-HA Film 7.4 1.0 75 
Insoluble SF Film (F1) 7.4 0.1 53 
Insoluble SF Film 7.4 - 53 
Drug Loaded SF-HA Film (F9) 7.4 0.1 66 
 
In addition to all, complex films prepared with SF and HA were found to be 
highly resistant to both acidic and alkaline conditions even at elevated temperatures up 
to 50°C as no disintegration or disassociation was observed during the experiments. 
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Figure 5.23. pH responsive changes of water content in SF-HA complex films. 
  
Figure 5.23 shows pH responsive changes of the swelling ratio (%) in the SF-HA 
film. The biopolymeric film swelled at alkaline condition (pH 7.4) and shrank at acidic 
condition (pH 2.5). Expansion and shrinkage was repeatedly reversible in response to 
change in pH.  
In literature, numerous drug delivery systems based on swelling-controlled 
mechanism in response to variations in environmental conditions, e.g. pH, have been 
reported (Gupta et al. 2002).  The polymeric network mesh-size of these systems 
showed changes with swelling, which permitted or prevented the release of the drugs. 
Swelling experiments employed to SF-HA complex films showed the films responded 
to the variations in pH regardless of the changes in temperature, which represented that 
SF-HA complex films may be utilized in pH-responsive systems for intelligent drug 
delivery.  
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5.4. Drug Permeability and Release Studies 
 
5.4.1. Permeability of TM Through SF-HA Complexes 
 
The permeation of the model drug, timolol maleate (TM), through SF-HA 
complex film was studied in buffer solution at pH 2.5 and 7.4, at the minimum and 
maximum swelling conditions determined at the previous section, respectively. Figure 
5.24 showed the permeation behaviour of TM through SF-HA complex film (F4) at 
different pH media at 37°C.  
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Figure 5.24. Timolol maleate concentration in permeate through SF-HA complex film at 
pH 7.4 and 2.5. 
 
Overall equation for permeation of the permeation is given by Eqn. (5.6): 
 
     )( RD CCPJ −=          (5.6) 
 
where J is the overall flux; P is the overall permeation coefficient; CR is the solute 
concentration in the receptor vial at time t and CD is the initial solute concentration of 
the donor vial. 
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 Permeation of drugs was assumed to obey Fickian’s law. As such, permeability 
coefficients are determined based on the following Eqn. (5.7) (Li et al. 2002): 
 
          Pt
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where VD and VR is the volume of the donor and receptor vial respectively (VR = 180 ml, 
VD = 20 ml), A  is the effective area of permeation (A=1.5 cm2). Thickness of the film 
was 200 µm. 
The evaluated permeabilities of the SF-HA complex films were 12.3x10-3 cm/s 
and 7.1x10-3 cm/s at pH 7.4 and 2.5, respectively. The results revealed that the direct 
correlation between the decreasing of the permeability (P), as shown in Figure 5.24, 
with the decreasing pH. The dependence of P on pH was explained by free volume in 
the film (Yoshizawa et al. 2004). In the systems having the swelling capability, the 
effective free volume is derived from the free volume of water, and the transport of 
solutes is presumed to permeate through the free-water region in the swollen film (Fang 
et al. 1998). As shown in Figure 5.24, SF-HA complex film swelled at higher rates at 
high pH. Due to the fact that the total volume of pores and channels in a unit volume 
increases, the amount of solute transport increase with respect to swelling. On the 
contrary, as the volume of the pores decreased at low pH, P decreased. 
 
5.4.2. Passive vs. Iontophoretic Delivery of TM 
 
The profiles for the passive (current density: I/A = 0) delivery and iontophoretic 
(current density: I/A = 0.5 mA/cm2) transport of TM through SF-HA film (F4) were 
represented in Figure 5.25 (a) and Figure 5.25 (b), respectively. Drug loading (5 mg/ml) 
was employed to the donor compartment at the 15th min. The iontophoretic delivery 
dose was 60 mA.min (1.5 mAx20 min) for each pulses, which were followed by 20 min 
of passive initial section as shown in Figure 5.25 (d). The higher release observed for 
the first pulse of the iontophoretic application could be due to a burst effect in which the 
drug present on the surface layer of the membrane was released instantly upon contact 
with the receptor solution, maintained under sink conditions. It was also observed that 
lag time of the membranes decreased after each pulse, which showed that applied 
electric field also caused reversible changes in the membrane morphology. This was 
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assigned as reversible since passive drug delivery rate was reached to initial values after 
each pulse. 
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Figure 5.25. TM delivery profiles through SF-HA complex film. TM permeation 
through the film in passive mode (a), iontophoretically assisted TM 
permeation form the film (b), release (c) from the drug loaded film,  
(d) applied electric field profile. 
 
Consequently, the instantaneous flux raised as the current was applied and then 
declined when the current application was terminated, and this process was repeated on 
subsequent applications. This showed that the release of TM by permeation through 
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SF/HA complex membranes was enhanced by iontophoresis applied in pulsate fashion. 
This represented that these membranes can be modulated for iontophoresis applications.  
Total mass balance calculations showed that the decline on the peaks caused by 
two reasons: decrease in the drug concentration in the donor compartment and fouling 
caused by adsorption of the drug on the membrane surface.  In literature, it was reported 
that high adsorption of the drug to the membrane, besides the loss of valuable drug 
molecule, probably caused fouling of the material, which influences the membrane’s 
permeability (Stamatialis et al. 2002). Since the film was shown to be negatively 
charged in all pH levels, and the drug molecule was positively charged, ionic 
interactions may have accelerated the possible adsorption mechanism. 
 Drug release from the drug loaded SF-HA complex films (F9), Figure 5.25 (c), 
with or without current application was practically same. Formation of strong 
interactions between the drug and the coacervate complexes led to indistinguishable 
release. Denser membrane structure formed due to strong interactions did not permit the 
drug release from the film even up to 65% swelling was observed. This also showed that 
swelling degree as well as the porosity and pore size distribution had an important effect 
on drug release.  
 These results showed that SF-HA complex system can be used in iontophoretic 
drug delivery systems as a membrane controlling the release of the drug rather than a 
drug loaded matrix.  The response of the system to electric field may have achieved by 
two mechanisms: electro-repulsion (migration) of the drug through the complex film 
under the applied electric field and/or the response of the complex film to the applied 
electric field, which would have increased the permeability of the film.  
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CHAPTER 6 
 
CONCLUSION 
 
This study focused on formation of silk fibroin (SF) – hyaluronic acid (HA) 
complexes and the potential use of SF-HA complex films in drug release systems.  
SF-HA complex coacervation was investigated and it was shown that the 
complexation was dominantly induced by pH that determined charge states of the 
biopolymers. Thus, the pH range for the formation of insoluble and soluble complexes 
were determined with respect to pH of the complex mixture. Insoluble complex 
coacervate formation was observed within the pH range of 2.5-3.5. It was shown that 
the complexes were formed due to electrostatic interactions between SF and HA in this 
pH window, where these two biopolymers were oppositely charged. It was revealed by 
turbidimetric analysis that the formation of insoluble complexes were reversible and 
independent of total biopolymer concentration. Gravimetric analysis performed at 
constant pH showed that total biopolymer concentration and ratio of the biopolymers in 
the complex mixture influenced the amount and probably the size of the complexes 
formed. Formation of the insoluble complex was confirmed and detailed by 
conductometric and viscosimetric analysis. The complexation was evidenced by the 
decrease of the complex mixture viscosity by the formation of dispersion composed of 
aggregated coacervates. Formation of stronger and larger coacervates were confirmed 
by the minimum viscosity and the maximum turbidity observed in the system. These 
analyses determined the appropriate conditions for complexation of these two 
biopolymers conditions for the preparation of the complex films.  
The complex solutions were formed at pH 3.2 with a SF:HA weight ratio of 20-
30 where higher complexation yields may be obtained. The mixtures casted and dried at 
20°C and 65% RH resulted in insoluble complex films irrespective of the mixing order 
or mixing ratio. The films had a homogeneous texture with slightly improved 
mechanical properties. It was also shown that drying had a crucial effect on the 
formation of the insoluble continuous films. The instrumental analysis performed 
revealed the consequences of complex formation between HA and SF. It was also 
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shown that the complex films comprised mixtures of crystalline and non-crystalline 
regions. 
Swelling tests performed on the complex films exhibited that the films swelled 
more in alkaline condition and had a pH-responsive swelling behavior. No effect of 
temperature was observed on swelling characteristics of the films at various pH 
conditions.  The films loaded with the model drug, timolol maleate (TM) showed less 
swelling which was attributed to formation of stronger interaction between the 
positively charged drug molecules and negatively charged excess of HA during the 
formation of drug loaded films. This result was confirmed with the FT-IR analysis.  
SF-HA complex films exhibited higher permeability for TM at alkaline 
condition which was consistent with the swelling tests.  Swelling test also revealed that 
SF-HA complexes can be good candidates for intelligent drug delivery systems, in 
which drug release is based on the response of the system to the environmental 
conditions.  
Drug release studies showed that the drug permeation through SF-HA complex 
films was enhanced by iontophoresis. The permeation of TM was controlled by the 
applied electric field in pulsatile fashion. On the other hand, drug loaded complex film 
did not give any response to the electric field which was reasonable with the formation 
of stronger complexes leading to formation of denser films.  
Consequently, SF-HA complex films were found to be promising for 
iontophoretic drug delivery applications for membrane-permeation-controlled systems, 
rather than a matrix system in which drug was imprinted. 
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APPENDIX A 
 
PREPARATION OF DIALYSIS TUBING 
 
The dialysis tubing was prepared by cutting 30 cm-long tubing from the roll. 
Initially the glycerin is removed by washing the tubes in running water for 3-4 hours. 
After the washing step, the sulfur components are removed by treating the tubes with a 
0.3 % (w/v) sodium sulfide solution at 80°C for one minute. Then it is washed with hot 
water at 60°C for 2 minutes. It is followed by acidification with 0.2% (v/v) sulfuric acid 
and rinsing with hot water to remove the acid. As a result of this process, tubing is 
proposed to retain most proteins of molecular weight 12,000 and greater. 
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APPENDIX B 
 
CALIBRATION CURVES 
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Figure B1. Calibration curve of TM dissolved in PBS at pH = 7.4 evaluated 
at λ = 294 nm in UV-visible spectrophotometer. 
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Figure B2. Calibration curve of TM dissolved in PBS at pH = 2.5 evaluated 
at λ = 294 nm in UV-visible spectrophotometer. 
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Figure B3. Calibration curve of aqueous SF solution evaluated 
at λ = 272 nm in UV-visible spectrophotometer. 
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Figure B4. Calibration curve of aqueous HA solution evaluated  
at λ = 217 nm in UV-visible spectrophotometer. 
